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Abstract

The high affinity iron scavenging glycoprotein transferrin sequesters trace
amounts of serum Fe3+ to concentrations below what is required to sustain
microbial life. Iron may be liberated from this important innate immune factor
after interaction with molecules that chelate or reduce Fe3+. Organisms with
cognate transport systems for these iron coordinating molecules can survive in
the bloodstream using transferrin iron.
Staphylococcus aureus is an opportunistic bacterial pathogen. S. aureus
executes numerous strategies for overcoming the innate immune barrier of iron
deprivation in the bloodstream. In addition to specialized mechanisms for
hemoglobin iron extraction, S. aureus can proliferate on serum iron, but factors
enabling this growth are not described. Production of at least two siderophores
(microbial iron chelators) has been documented on numerous occasions, and
their contribution to growth on transferrin is documented here. Genomic
inactivation of genes involved in production of molecules subsequently termed
staphyloferrin A (SA; the sfa locus) and staphyloferrin B (SB; the sbn operon)
resulted in a mutant severely incapacitated for growth in serum as well as on
rarefied human transferrin as sole iron sources. Transport of staphyloferrins
was correlated to adjacently encoded cognate ABC type transporter operons,
hts (SA) and sir (SB), using previously constructed transport mutant strains.
Mass spectrometry confirmed the molecular structure of SB as being the same
as the previously described S. aureus metabolite, staphylobactin.
Alternate siderophores were not detectable for the double biosynthetic
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mutant. Growth in the presence of transferrin could be rescued by addition of
saturating concentrations of iron, and restored by molecules that bind Fe3+
through catechol-iron coordination, including mammalian catecholamine stress
hormones. In silico analysis and mutational inactivation confirmed this transport
function to be encoded by the sst operon. Biochemical assays revealed that the
Sst transporter lipoprotein has a high affinity for ferrated catecholate iron
ligands.
Siderophore biosynthesis and transport mutants displayed reduced
virulence during systemic mouse infection. Decreased bacterial loads were
documented in mouse hearts, an important finding as S. aureus is a leading
cause of endocarditis. The data collected in this study show that acquisition of
serum iron is an important part of staphylococcal pathogenesis, and suggest
that therapeutics targeting the numerous facets of this process may be effective
in combating invasive infection.

Keywords: Staphylococcus aureus, siderophores, staphyloferrin A,
staphyloferrin B, serum, transferrin, ABC transporters, catecholamine hormones,
catechol siderophores, mouse infection model
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Chapter 1
Introduction

2
1.1 Iron
1.1.1 Iron chemistry
With the exception of some lactobacilli and spirochaetes (8, 204), iron is an
essential nutrient for bacteria. Iron is most commonly found in Fe(II) (ferrous)
and Fe(III) (ferric) valence states; however, it is able to achieve valence ranging
from Fe(-II) to Fe(IV), and is amenable to ligand-mediated transition through a
redox range of -750 to +1150 mV at neutral pH (198), making it an exceptionally
versatile catalyst. The heme centre of cytochromes is crucial to respiratory and
photosynthetic ATP biosynthesis; Fe–S clusters are central to redox reactions
mediated by proteins such as nitrogenase and hydrogenase; and iron is a
cofactor for numerous other metalloproteins. In aerobic, oxidizing environments,
iron predominates in the ferric form (Fe3+), forming poorly soluble hydroxides. A
widely cited calculation describes the primary Fe3+ species in pH neutral solution
to be Fe(OH)3, restricting solubility to 10-18 M (93, 225). A revised solubility
calculation posits Fe(OH)2+ to be the primary species, improving solubility to
almost 10-9 M (41); nevertheless, this is below the threshold required to sustain
microbial life in the absence of specialized acquisition mechanisms.

1.1.2 Iron toxicity
In spite of low solubility, residually soluble iron is a hazardous catalyst.
Fe2+ readily reacts with hydrogen peroxide, generating hydroxyl radical, as
shown in equation 1 (105). Soluble Fe3+ is renewed to Fe2+ by reaction with
superoxide, shown in equation 2 (13).

3
Fe2+ + H2O2  Fe3+ + OH• + OH-

(equation 1)

Fe3+ + O2-  Fe2+ + O2

(equation 2)

Hydroxyl radical generated through equation 1 is extremely cytotoxic,
being reactive with cell membranes (19), and inducing single and double strand
breaks in DNA (30, 252). To mitigate toxicity of catalytic iron, most biological
systems control iron levels tightly using high affinity storage and transport
proteins, described below.

1.2 Iron absorption and storage in mammalian systems
1.2.1 Iron absorption
The average human body contains three to four grams of iron (26). The
process of absorption from dietary sources, reviewed here (5, 75), occurs
principally in the duodenum. Briefly, Fe3+ is reduced to readily soluble Fe2+ by
the low pH of the intestinal lumen, and by the duodenal cytochrome B (DCytB),
found on the apical membrane of the duodenal enterocyte. Fe2+ is transported
into enterocytes through a proton-coupled solute transporter, DMT1. Release of
Fe3+ from erythrocytes into plasma occurs through a solute carrier, ferroportin.
In plasma, Fe3+ is bound by the carrier protein transferrin, which is described in
detail below.
A surplus of bodily iron stimulates release of the peptide hormone hepcidin
from the liver. Hepcidin binds to ferroportin on enterocytes, triggering its
degradation and internalization. Rather than being passaged into plasma,
subsequently absorbed dietary iron is instead compartmentalized within the
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protein ferritin (described next), and excess iron can be shed through sloughing
of enterocytes into the feces.

1.2.2 Bodily iron reservoirs: ferritin
Ferritin is a stable, hollow, 450 kDa proteinaceous sphere composed of 24
“heavy” and “light” subunits, capable of harbouring up to 4500 Fe3+ atoms (35).
Ferritin is an important component of iron homeostasis in the body, specifically
in regards to storage of surplus iron in a soluble and nontoxic form, and is found
with high conservation in eukaryotes and prokaryotes alike (7). In animals,
ferritin is most abundant in liver hepatocytes, which act as the body’s primary
iron reserve (25). Release of ferritin into serum may aid in iron delivery from the
liver to other tissues (73, 86). More importantly, elevated serum ferritin serves
to reduce iron overload caused by hemochromatosis or some cancers (262).

1.2.3 Bodily iron reservoirs: heme and heme carrier proteins
The majority of iron in humans is found within heme prosthetic groups of
metalloproteins, including peroxidases, cytochromes, and most abundantly, in
the hemoglobin of erythrocytes, which contain around two-thirds of the total
bodily reservoir (69). Variations on heme structures exist. The primary
mammalian form is heme-b, a planar molecule composed of a large heterocyclic
ring (protoporphyrin IX) with four central nitrogen atoms coordinating one atom
of ferrous iron. The two remaining uncoordinated positions of heme iron permit
interactions with axial ligands, including histidine/cysteine/methionine/tyrosine
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residues of heme carrier proteins, water, or small molecule aqueous solutes, the
most noteworthy being oxygen.
The largest reservoir of bodily heme is the circulatory hemoglobin pool.
Hemoglobin is a globular heterotetramer found within erythrocytes whose
primary function is to bind O2 to heme prosthetic groups and deliver it from the
lungs to all other tissues. Human blood contains approximately 1.3 x 1018
hemoglobin tetramers per mL (adapted from reference range provided by the
Department of Pathology at the University of Texas Southwestern Medical
Centre). Erythrocyte lysis and oxidative hemoglobin degradation leads to heme
liberation into serum. Owing to its hydrophobicity, heme can intercalate into lipid
bilayers, and is reactive with H2O2, producing hydroxyl radicals that lead to
tissue damage (219). Capture of extracellular heme is a vital maintenance
function for bodily well being and mechanisms exist for its removal.
Serum hemoglobin is scavenged by the glycoprotein haptoglobin (88).
Haptoglobin irreversibly forms a soluble complex with hemoglobin. The complex
is recognized by a specific receptor expressed on the surface of macrophages,
internalized, then degraded (138). Iron captured in this fashion is released back
to the serum in hemosiderin, a molecular aggregate comprised mostly of ferritin
and denatured ferritin (71, 119, 270). Serum heme is readily bound by low and
high density lipoprotein (175). This binding is transient, as the heme is then
gradually removed by the glycoprotein hemopexin (120). Hemopexin delivers
heme back to the liver, where it is internalized by receptor-mediated
endocytosis; hemopexin is a true iron carrier protein, as it is released back into
circulation undegraded (121).
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1.2.4 Bodily iron reservoirs: transferrin and lactoferrin
Less than 5 mg of bodily iron (<0.1%) is found in the labile pool circulating
within serum and lymph (adapted from (256)); this fraction, however, undergoes
the highest turnover. After ferroportin-mediated export of dietary Fe3+ occurs
from intestinal enterocytes, the binding and redistribution of iron in serum is
performed chiefly by transferrin, an 80 kDa glycoprotein synthesized by the liver.
The transferrin reference range for healthy adult serum is roughly 25 to 30 µM
(adapted from (12)). Transferrin has two high affinity Fe3+ binding sites, with
equilibrium constants of 4.7 x 1020 M-1 and 2.4 x 1019 M-1 at physiological pH;
both have negligible affinity for Fe2+ (3). Binding of Fe3+ at either site is random
and noncooperative (1). Serum transferrin is about 30% iron saturated in
healthy individuals; saturation below 20% is a clinical indicator of iron deficiency
(269). Transferrin is the primary agent of circulatory iron distribution, and its
mode of action is summarized here (122). Briefly, upon contacting recipient
tissue cells, ferrated (holo) transferrin binds a ubiquitously expressed cell
membrane receptor. The amount of receptor found on a cell membrane is
directly proportional to the cell’s iron demand. Binding triggers endocytosis and
internalization within a vesicular compartment, which is acidified to promote
dissociation of iron. Fusion of the vesicle with the cell membrane returns
deferrated (apo) transferrin, to the cell surface, where it is released back into
circulation. Percent saturation of serum transferrin is sensed through the
transferrin receptor and an interacting protein, human hemochromatosis factor
(HFE protein), with increased saturation being a key stimulus for upregulation of
hepcidin production, decreasing absorption of dietary iron (83).
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The glycoprotein lactoferrin is highly related to transferrin in sequence
(61.4% identical) and structure (260). This iron scavenging protein is found
primarily in secretions such as mucus, milk, and tears, and releases iron at a
much lower pH than transferrin (pH 3.0 vs 5.5) (11). It is also released by
polymorphonuclear leukocytes as an antimicrobial agent during degranulation
(47). Lactoferrin has no demonstrated role in iron transport, but is an important
contributor to bacteriostasis in tissues and bodily fluids, by reducing the amount
of iron available to pathogens (206, 210); this aspect of bodily iron homeostasis
is discussed next.

1.2.5 Iron sequestration and innate immunity
Restricting iron availability is crucial for limiting the spread of infection in
blood. Conversely, iron overload associated with diseases such as
hemochromatosis increases susceptibility to bacteremic infection (130). The
inflammatory response involves suppressing uptake of dietary iron. This
renders serum anemic, a phenomenon known as hyposideremia. In this
fashion, uptake of dietary iron can be further reduced even if transferrin
saturation is already low. Hepcidin production by the liver and spleen is
increased during inflammation (187, 199), and this is mediated at least in part by
cytokines interleukin-6 (185) and interleukin-1α and 1β (142). Hepcidin binding
to ferroportin on intestinal enterocytes triggers degradation of this transport
protein and reduces absorption of dietary Fe3+ (186).
Hyposideremia also involves increasing levels of circulating iron binding
proteins. Serum ferritin levels increase due to upregulated secretion by hepatic
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cells in response to interleukin-1 (217, 254). Serum lactoferrin increases during
septicemia and viral infection, as degranulating neutrophils deliver lactoferrin to
sites of infection, leading to localized sequestration of iron (103, 163, 208).
Hepatocyte secretion of the hemoglobin/heme removal proteins haptoglobin and
hemopexin is also upregulated during the acute phase response (158, 263).
Only one serum iron transport protein is maintained at a stable concentration
during inflammation: transferrin (191). Its contribution to innate immunity should
not be understated, however. The iron binding capacity of the transferrin pool is
routinely high, as average saturation rarely exceeds 50% (214). When dietary
absorption is repressed by acute phase increases in circulating hepcidin, the
labile transferrin-bound iron supply is more rapidly depleted by erythropoiesis
(205), effectively increasing the iron binding capacity of serum.

1.3 Bacterial strategies for acquisition of host iron
1.3.1 Active transport of iron ligands: an overview
As outlined above, animal serum maintains a consistently low level of
freely dissolved iron through complexation to an abundant pool of transferrin.
The labile iron pool may be further depleted through enhanced production of
other serum iron scavenging proteins during the acute phase inflammatory
response to disease. This effectively limits the amount of free iron below the
threshold required to support microbial growth, meaning invasive pathogens
must respond by expressing specialized, high affinity iron transport systems.
Bacteria import iron from the host milieu primarily as a liganded substrate.
This can include heme extracted from host carrier proteins, or Fe3+ coordinated
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by bacterial or host-synthesized molecules in a stable and kinetically labile
arrangement. At the bacterial cytoplasmic membrane, most examples of iron
transport are active processes involving ATP-binding cassette (ABC)
transporters (Figure 1-1). These systems comprise three functional domains.
The first is a high affinity receptor for recognition of the transported substrate; in
Gram-positive bacteria this is covalently linked to the cytoplasmic membrane at
a N-terminal lipidation motif, while in Gram-negative bacteria it is usually freely
soluble in the periplasmic space. The second domain comprises the permease,
a homodimeric or heterodimeric transmembrane domain which associates with
the receptor and permits solute transport through the lipid bilayer. The final
domain is an ATPase, a cytosolically-located, permease-associating, dimeric,
ATP-hydrolyzing unit. The different components of the ABC transporter are
usually distinctly translated proteins, but examples of translational domain
fusions exist. (For a more comprehensive review on bacterial ABC transporters,
see (52).)
In Gram-negative bacteria, the presence of an outer membrane and a
periplasm necessitates additional components for substrate capture
(Figure 1-1). An outer membrane receptor protein is involved in substrate
recognition. A cytoplasmic membrane complex, comprising proteins TonB,
ExbB, and ExbD, captures energy generated by proton motive force across the
cytoplasmic membrane to drive substrate transport through the outer membrane
receptor into the periplasm. The outer membrane receptor is a pore-forming
β-barrel protein occluded by a N-terminal β-sheet “plug” domain.
Conformational changes induced by ligand binding and interaction with TonB
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Figure 1-1: Model of active ligand transport in Gram-negative and Grampositive bacteria. (A) Model of transport in Gram-negative bacteria. Substrate
(yellow star with red centre) is recognized at the outer membrane by the outer
membrane receptor (OMR) and transported into the periplasm with energy
provided by the Ton complex (TonB/ExbD/ExbB). A periplasmic binding protein
(PBP) captures the substrate and delivers it to an ABC transporter comprising a
homo- or heterodimeric permease (P) and dimeric ATPase (A), the latter
hydrolyzing ATP to drive translocation of the substrate into the cytoplasm.
(B) Model of transport in Gram-positive bacteria. Substrate at the outer face of
the cytosolic membrane binds to a receptor lipoprotein (LP) and is translocated
through a permease (P) with energy coming from ATPase-mediated (A) ATP
hydrolysis.
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move the plug to relieve occlusion, permitting translocation of the substrate to
the periplasm, where it is recognized by the periplasmic binding protein. (For
excellent, comprehensive reviews of Gram-negative transport across the outer
membrane and periplasm, consult (66, 137).)

1.3.2 Heme uptake: capture from heme carrier proteins
The majority (~65%) of bodily iron is found in heme groups of hemoglobin,
sequestered in red blood cells (48). The overwhelming abundance of
hemoglobin in the mammalian host has selected for pathogens capable of
exploiting this iron pool using specialized uptake mechanisms. In
Gram-negative bacteria, heme uptake is initiated by binding of heme or
hemoproteins to a bacterial outer membrane protein. In the case of Neisseria
spp., two independent outer membrane receptors are involved. HmbR is a
β-barrel/plug protein which recognizes heme and hemoglobin (242). HpuAB is a
bipartite receptor, involving a β-barrel outer membrane protein (HpuB) working
in concert with an outward facing lipoprotein (HpuA); this complex binds
hemoglobin as well as hemoglobin-haptoglobin (148). Some bacterial outer
membrane receptors recognize a variety of host hemoproteins; PhuR from
Pseudomonas aeruginosa can bind heme, hemoglobin, haptoglobinhemoglobin, and hemopexin (192). The mechanism(s) by which receptor
proteins disengage heme from the host protein are not well described.
Following extraction, passage of heme through the periplasm may require a
periplasmic binding protein, as exemplified by PhuT of P. aeruginosa; this also
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serves as the receptor component of the ABC-type transporter at the
cytoplasmic membrane (248).
Heme capture by Gram-positive bacteria has received less scrutiny.
Recognition of hemoproteins by pathogens including Staphylococcus aureus,
Bacillus, and Group A Streptococcus occurs at the outer face of the cell wall and
requires a complement of cell wall-anchored proteins that bind hemoproteins,
extract heme, and serially passage it through the peptidoglycan to cytoplasmic
membrane ABC transporters (84, 152, 168, 277). The iron-regulated surface
determinant (Isd) system of S. aureus is fairly well understood and will be
described in more detail in a later section.

1.3.3 Heme uptake: hemophores
Hemophores are secreted proteins that extract heme from solution or from
heme carrier proteins and deliver it to the bacterial cell. The HasA hemophores
form a unique, highly conserved family of proteins produced by pathogenic
bacteria including Serratia marcescens (144), P. aeruginosa (146), and Yersinia
pestis (218). HasA binds a large number of heme carrier proteins, including
hemoglobin and hemopexin (261). Due to its binding affinity for heme
exceeding that of host carrier proteins, transfer of heme is passive (145). An
active, TonB-dependent transfer occurs at the bacterial surface, where outer
membrane receptor protein HasR initiates passage of the heme molecule into
the periplasm and toward the cytoplasmic membrane (143). Hemophore
production by Gram-positive bacteria has been documented only for Bacillus
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anthracis, which secretes soluble proteins with heme-binding motifs homologous
to those found in its Isd system (157).

1.3.4 Direct uptake of Fe3+ from transferrin
Some bacteria secure transferrin and lactoferrin iron through direct binding
and manipulation of these serum proteins using cell surface receptors. The best
documented transferrin receptor system is found in Neisseria spp. This involves
a bipartite outer membrane receptor complex, TbpAB, that binds transferrin and
conformationally manipulates it to force release of Fe3+ (44, 150). TbpB, the
outer membrane β-barrel protein, delivers Fe3+ to periplasmic chaperone FbpA;
surprisingly, this transfer is not energetically dependent on TonB (194).
FbpABC form an ABC-type transporter for active uptake of Fe3+ into the
bacterial cytoplasm (131). Sporadic reports of transferrin binding by cell wall
proteins of Gram-positive bacteria exist (111, 177, 247), but mechanistic data
are lacking; this phenomenon may merely reflect the promiscuity cell wall
adhesion factors demonstrate in interacting with a range of host molecules.

1.3.5 Indirect uptake of Fe3+ from transferrin: siderophores
Siderophores are small, high affinity Fe3+ chelators secreted by numerous
bacteria, fungi, and plants in response to the stress of iron limitation. They
scrounge soluble ferric iron or compete for it with other high affinity iron
chelators. As will be discussed in greater detail in ensuing sections,
siderophores come in a wide variety of molecular structures (also reviewed here
(113)). Cellular uptake is preceded by ligand recognition through cell surface
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receptors that are highly specific for particular molecular features of the
substrate, rendering siderophore iron a privilege of organisms equipped with
cognate transporters. Many siderophores are competitive with transferrin and
lactoferrin for iron binding, and siderophore production has been shown to
contribute to growth of numerous bacteria in serum (Table 1-1).

1.3.6 Indirect uptake of Fe3+ from transferrin: catecholamine stress
hormones
The low affinity of transferrin and lactoferrin for Fe2+ means their function
may be compromised by interaction with agents that reduce Fe 3+. Recent
studies have demonstrated that the catecholamine stress hormones, including
adrenaline (epinephrine), noradrenaline (norepinephrine), dopamine, and
L-3,4-dihydroxyphenylalanine

(L-DOPA), are capable of forming direct

complexes with holotransferrin and hololactoferrin, and reductively liberating iron
as Fe2+ (80, 220). Although Fe2+ is readily reoxidized in biological fluids,
catecholamines have been proposed to provide the hexadentate coordination
required to stabilize Fe3+ in solution via their catechol moieties, in a 3:1 molar
ratio (220); thus these hormones may also act as biological chelators that
compete with transferrin.
Elevated levels of catecholamines have been correlated to higher rates of
postoperative sepsis (99) and experimental elevation of systemic norepinephrine
has been shown to promote translocation of enteric bacteria in mice (156).
Addition of catecholamines stimulates growth on transferrin or serum for
pathogenic bacteria including Bordetella bronchiseptica (6), Escherichia coli
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Table 1-1: Siderophores contributing to growth of bacteria in the presence
of transferrin or in serum
Species

Siderophore

Ref.

Aeromonas spp.
Bordetella bronchiseptica
Burkholderia cepacia
Escherichia coli
Mycobacterium spp.
Pseudomonas aeruginosa
Pseudomonas pseudomallei
Salmonella enterica
Staphylococcus aureus
Vibrio parahaemolyticus
Vibrio vulnificus
Yersinia pestis

Amonabactin
Alcaligin
Salicylic acid
Aerobactin, enterobactin
Exochelins
Pyoverdin, pyochelin
Malleobactin
Salmochelin, enterobactin
Staphyloferrins A and B
Vibrioferrin
Vulnibactin
Yersiniabactin

(161)
(78)
(233)
(135)
(59, 90)
(238)
(276)
(265)
This study
(274)
(151)
(67)
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(220), and Staphylococcus epidermidis (184).

1.3.7 Uptake of Fe2+
Under aerobic (oxidizing) conditions, iron predominates in solution as Fe 3+;
under anaerobic or microaerophilic conditions, however, transport of Fe2+ is a
relevant iron uptake strategy for many bacteria, involving the Feo (ferrous iron)
transport system. First characterized in Escherichia coli (107, 127), this
comprises two or three proteins: 1) FeoB, a large protein with an integral
membrane domain, acting as the permease component (127), and a N-terminal
G-protein domain, acting as a GTPase driving active transport of Fe2+ (159);
2) FeoA, a small, cytosolic protein that activates the GTP-hydrolyzing activity of
FeoB; 3) FeoC, a small hydrophilic protein associated only with γ-proteobacterial
Feo systems, that may be a transcriptional repressor (32). FeoB-mediated iron
uptake from the gastrointestinal tract contributes to colonization by and
pathogenesis of Campylobacter jejuni (183) and Helicobacter pylori (258); FeoB
also contributes to intracellular growth of Legionella pneumophila (215).
FeoB-mediated uptake of Fe2+ could theoretically work in concert with
mechanisms that reductively convert Fe3+ on or around the bacterial surface.
Extracellular ferric reductase activity has been reported for several bacteria
(224, 257), but few reports empirically demonstrate a role for this phenomenon
in microbial iron acquisition. Insofar as extracellular reduction contributes to the
iron uptake strategy of pathogenic bacteria, this has only been shown for
capture of transferrin and lactoferrin iron by Listeria monocytogenes under
anaerobic conditions (14).
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1.4 Siderophores
1.4.1 Siderophore chemistry and iron coordinating groups
Numerous plants, fungi, saprotrophic bacteria, and bacterial pathogens
secrete small molecules called siderophores to serve as high affinity Fe 3+
scavengers. Siderophores are assembled from amino acids, organic acids, and
other small organic metabolites. Huge diversity has been documented in terms
of the structure and iron-binding affinity of these compounds, although some
broadly shared themes describe their physicochemical properties (for more
comprehensive reviews, see (49, 171, 261)). Siderophores are small, being
typically less than 1 kDa in mass. They are highly electronegative and surround
Fe3+ to form a hexacoordinated complex involving three bidentate coordinating
sites, although the stoichiometry of iron atoms to siderophore coordinating
groups may vary if surrogate oxygen, nitrogen, or sulfur donors from solution
compensate for vacancies. The stoichiometry of siderophore molecules to iron
atoms may also deviate from 1:1 if the siderophore has more or less than three
coordination moieties; rhodotorulic acid, for instance, has four, and coordinates
iron in a 2:3 (Fe3+:siderophore) molecular ratio.
In general, three types of functional groups can act as siderophore iron
coordination motifs (Figure 1-2A). First are the adjacent hydroxyl groups of
catechol moieties (ortho-dihydroxybenzene), exemplified in the enterobactin
structure (Figure 1-2B) (123). This siderophore group forms extremely stable
ligand-Fe3+ complexes and includes some of the strongest known iron chelators.
Most functional groups of catecholate siderophores are derived from a common
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Figure 1-2: Siderophore Fe3+ coordination group types. (A) Siderophores
coordinate Fe3+ in solution using catecholate, hydroxamate, or carboxylate
moieties (Fe3+-coordinating atoms in red). (B) Examples of siderophores
include enterobactin (catecholate coordination), coprogen B (hydroxamate
coordination), rhizoferrin (carboxylate coordination), and petrobactin (mixed
catecholate and carboxylate coordination) (Fe3+-coordinating atoms in red).
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precursor, 2,3-dihydroxybenzoic acid (Figure 1-3) (49). This molecule is itself
capable of coordinating Fe3+ in a 3:1 molecular ratio, and is secreted as a
siderophore by bacteria including Brucella abortus (154), Azospirillum lipoferum
(222), and Rhizobium leguminosarum (195). Structurally similar biological
molecules, including mammalian catecholamine stress hormones (Figure 1-3),
have also been proposed to coordinate iron in solution; invasive bacteria with
cognate transport systems could theoretically capitalize on these to meet
nutritional iron demands (220).
The second type of siderophore iron coordination involves hydroxamate
motifs (Figure 1-2A), where adjacent carbonyl and aminohydroxyl groups
provide an iron coordination site, as in coprogen B (Figure 1-2B) (271). This
chemistry is frequent among fungal siderophores. The third type of coordination
involves carboxylate motifs (Figure 1-2A). These may involve two sites provided
by α-hydroxycarboxylates derived from citrate, or from carboxylic acid moieties,
as in rhizoferrin (Figure 1-2B). Numerous siderophore molecules, such as
petrobactin (Figure 1-2B) and aerobactin use combinations of the three iron
coordinating groups (110, 141).

1.4.2 Nonribosomal peptide synthetase assembly
Siderophore assembly pathways fall into two broad classes: nonribosomal
peptide synthesis (NRPS) and NRPS-independent siderophore (NIS) synthesis
(34). NRPS siderophores involve polypeptidic scaffolds, often incorporating
nonproteinogenic amino acids and their derivatives, assembled without the
benefit of a ribosomal template (49). Numerous NRPS siderophores have been
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Figure 1-3: 3:1 coordination of Fe3+ in solution by small catecholate
molecules. (A) Coordination of Fe3+ by three molecules of 2,3dihydroxybenzoic acid (DHBA). (B) Catecholamine stress hormones, which
have been proposed to coordinate Fe3+ in an arrangement mimicking DHBA.
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described, including enterobactin (207), yersiniabactin (173), and vibriobactin
(129). Important antibiotics such as penicillin (223) and vancomycin (244) are
also NRPS metabolites. Independently of a ribosome, NRPS siderophores are
condensed and modified stepwise on a multimodular enzyme, the NRP
synthetase, for which the roles of functional domains can be summarized as
follows (243): 1) Activation of an amino acid or growing intermediate
aminoacyl-AMP by adenylation domains; 2) Transfer to peptidyl carrier protein
(PCP) domains; 3) Condensation of PCP-bound amino acids by condensation
domains; 4) Amino acid modifications, for example by epimerization domains;
5) Transesterification (TE) of the peptide chain from the terminal PCP onto the
TE domain, with subsequent liberation of the mature metabolite through
hydrolysis or macrocyclization. The modular arrangement of the NRPS
synthetase essentially creates a protein assembly line, allowing metabolite
assembly and modification to occur in a progressive, stepwise fashion.

1.4.3 Nonribosomal peptide synthetase independent assembly
Less well characterized are the mechanisms for assembly of NIS
siderophores. These are created from the condensation of alternating subunits
of dicarboxylic acids (usually succinate, citrate, and α-ketoglutarate) with
diamines, amino alcohols, and alcohols (34). NIS synthetases are not
homologous to their modular counterparts in NRPS pathways. They primarily
serve to catalyze formation of amide and ester bonds between an organic acid
and a substrate bearing an amino or a hydroxyl group (34). Individual NIS
reactions are performed by individual synthetases. The proposed assembly of
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aerobactin represents the archetypal pathway of NIS biosynthesis (54, 55), even
though the biochemical roles of synthetases IucA and IucC have not been
empirically characterized. Elucidation of the molecular structure of other
siderophores and annotation of the genetic loci encoding their biosynthesis
suggest rhizobactin (155), achromobactin (79), vibrioferrin (246), and alcaligin
(128) are also assembled in an NRPS-independent fashion. Recent efforts have
described the pathway involved in production of petrobactin (141, 197), which is
a rare example of a siderophore assembled via a hybrid NRPS/NIS strategy.
A model has been proposed to classify NIS synthetases based on
specificity for a carboxylic acid (34, 126). Type A enzymes, represented by
IucA, catalyze condensation of a prochiral carboxyl group of citrate to an amine
or alcohol functional group of a second substrate, resulting in an amide or ester
bond, respectively. Type B enzymes catalyze a similar reaction substituting the
C5 carboxyl of α-ketoglutarate for the citrate carboxyl. Type C enzymes,
represented by IucC, catalyze condensation of monoamide/monoester
derivatives of citrate or succinate to carboxyl groups on molecules with an amine
or an alcohol. For the most part, predictions of NIS synthetase type based on
phylogenetic analysis have accurately described their role in functional enzyme
assays, but this is based on limited data, and at least one exception is known
and will be discussed in a later section. Additional modifications to precursors,
such as decarboxylation, isomerization, or oxidation, are performed by separate
enzymes typically encoded by genes clustering near to those encoding the
synthetases.
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1.4.4 Siderophore uptake and iron liberation
In Gram-negative bacteria, siderophore import to the periplasm is mediated
by outer membrane receptors and the Ton system, as previously described.
Siderophore transport across the bacterial cytoplasmic membrane is typically
performed by ABC-type transporters. Genetic loci for ABC transporters often
reside in close genomic proximity to loci involved in biosynthesis of the cognate
siderophore. Siderophore binding proteins sometimes exhibit plasticity in their
substrate affinity, recognizing multiple siderophores within the same iron
coordination chemistry. Examples include E. coli FhuA and FhuD, the outer
membrane receptor and periplasmic binding proteins, respectively, for
aerobactin and a broad host of exogenously derived hydroxamate type
siderophores (65, 136). Homologous FhuD lipoproteins in S. aureus also
recognize a variety of actively transported hydroxamate molecules (226).
Upon cellular internalization, two mechanisms may be used for liberation of
siderophore-bound iron. Extraction from exceptionally high affinity siderophores
often requires destruction of the molecule, while those with lower affinity may be
deferrated through a reductive mechanism. Both scenarios occur in E. coli.
Enterobactin, the strongest known siderophore (Kd = 1052 M-1), is cleaved by
esterase FesA at ester groups in the trilactone backbone, yielding subunits of
2,3-dihydroxybenzoyl-L-serine (43); concomitant reduction of Fe3+ occurs
through an unknown mechanism (29). On the other hand, the hydroxamate
siderophore aerobactin, with a more modest affinity for Fe3+, is acted upon by
cytoplasmic ferrisiderophore reductase FhuF, yielding Fe2+ for cellular
processes, and reusable aposiderophore (166).
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1.4.5 Contributions to virulence
Numerous studies have demonstrated the impact of siderophore-mediated
iron uptake on virulence, even among organisms capable of extracting host
heme iron; key reports are summarized in Table 1-2. Pathogenic bacteria may
also produce siderophores for survival outside of a host niche, and rely on other
iron uptake strategies in vivo; for instance, production of a catecholate
siderophore is important for survival of the veterinary pathogen Rhodococcus
equi as an environmental saprotroph, while having no significant impact on
virulence in a murine infection model (176).

1.4.6 Siderocalin and stealth siderophores
The lipocalins are a family of roughly 20 small, soluble proteins, produced
by prokaryotes and eukaryotes. Their three dimensional structure comprises an
eight-stranded anti-parallel β-barrel that forms a cavity capable of enclosing low
molecular weight solutes (77). The mammalian protein lipocalin-2, alternately
named neutrophil gelatinase-associated lipocalin or, pertinently to this study,
siderocalin, is secreted by macrophages and neutrophils during the
inflammatory response to bacterial antigens such as lipopolysaccharide, leading
to rapid rises in serum titres (76). Expression of recombinant siderocalin in
E. coli serendipitously revealed it binds the catecholate siderophore enterobactin
(91), and it is now known to sequester a variety of bacterial siderophores,
primarily those with catecholic or phenolic moieties (91, 116).
Siderocalin-deficient mice are more susceptible to sepsis and pneumonia
caused by E. coli strains that rely on enterobactin for siderophore-mediated iron
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Table 1-2: Siderophores contributing to the virulence of bacteria in animal
models of colonization or infection.
Species

Siderophore

Animal model

Ref.

Bacillus
anthracis
Bordetella
bronchiseptica
Bordetella
pertussis
Burkholderia
cenocepacia
Escherichia coli

Petrobactin

Mouse inhalation anthrax

(31)

Alcaligin

Neonatal pig intranasal
colonization
Mixed competition mouse
respiratory infection
Rat agar bead lung infection

(209)

(266)

Escherichia coli

Salmochelin

Mycobacterium
tuberculosis
Neisseria
gonorrhoeae
Pseudomonas
aeruginosa
Salmonella
enterica
Salmonella
typhimurium
Staphylococcus
aureus
Vibrio cholerae

Carboxymycobactin

Mouse intraperitoneal lethal
challenge
Mouse intraperitoneal lethal
challenge
Mouse aerosol inhalation
infection
Chicken embryo bacteremia
Burned mouse subcutaneous
infection
Mouse cecal colonization

(170)

Mouse intraperitoneal infection

(275)

Mouse sepsis

This
study
(112)

Vibrio vulnificus

Vulnibactin

Yersinia pestis

Yersiniabactin

Alcaligin
Ornibactin
Aerobactin

Gonobactin
Pyoverdin
Salmochelin,
enterobactin
Enterobactin
Staphyloferrins A
and B
Vibriobactin

Mouse suckling intragastric
infection
Mouse suckling intragastric
infection
Mouse pneumonic plague,
bubonic plague

(28)
(234)

(72)
(216)
(70)

(265)

(151)
(67)
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uptake (76, 272). Siderocalin is also capable of binding catecholamine stress
hormones (172), further enhancing bacteriostasis through iron sequestration.
The binding of iron chelators by siderocalin is not indiscriminate, and many
bacteria can subvert this immune factor by producing alternate, unrecognizable
siderophores, or by incorporating structural modifications or substitutions within
preexisting siderophore molecular templates. Siderocalin-evading siderophores
are frequently described using the adjective “stealth”. The salmochelin family,
for instance, includes enterobactin glucosylated at the C5 position of one or
more of the molecule’s catecholic arms (22), and 2,3-dihydroxybenzoylserine
subunits bridged by glucose residues (109). These enzymatic modifications to
siderocalin-cognate siderophores are mediated by genes encoded in the iroA
cluster, a virulence locus typically situated within pathogenicity islands or
plasmids of exceptionally virulent strains of E. coli and species of Salmonella
(17, 60, 236). Salmochelins are not bound by siderocalin, and iroA-expressing
E. coli strains are insensitive to its growth inhibitory effects (72).
The anthrax pathogen also employs a similar strategy for bypassing
siderocalin. B. anthracis produces two siderophores: petrobactin, which
coordinates iron using an unusual combination of one carboxylate and two
3,4-catecholate moieties (Figure 1-2B) (20), and the more conventional
bacillibactin, with three 2,3-catecholate-type coordination sites (167).
Petrobactin is the only siderophore known incorporating 3,4-catechols. Owing to
this unusual chemistry, petrobactin is not recognized by siderocalin, unlike
bacillibactin, for which siderocalin has exquisite affinity (2). Petrobactin but not
bacillibactin was found to contribute to the intracellular survival of B. anthracis in
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macrophages and in a murine subcutaneous anthrax model of infection (33).
This has been subsequently interpreted as proving a correlation between
siderocalin evasion and pathogenesis, although other observations reveal
bacillibactin to be dispensible in a range of host-independent conditions despite
a high affinity for Fe3+, convoluting the narrative that acquisition of petrobactin
biosynthesis is necessarily an evolutionary countermeasure to siderocalin.
Petrobactin but not bacillibactin is sufficient to sustain vegetative growth of
B. anthracis in chelated culture medium, and furthermore to induce vegetative
growth from dormant spores (33); the chronology of siderophore production at
the onset of vegetative growth proceeds as petrobactin first, bacillibactin second
(267). While petrobactin clearly contributes to the enhanced virulence of
B. anthracis, it may be inadequate to describe its evolutionary significance
based solely on its contribution toward virulence.

1.5 Bacterial regulation of iron transport mechanisms
1.5.1 The ferric uptake regulator is a conserved mechanism governing
bacterial transcriptional responses to iron limitation
A decrease in intracellular iron stores is a key sensory trigger for the
genetic expression of iron uptake mechanisms and virulence factors that play
roles in liberating host iron stores or circumventing host immune strategies. The
Fur protein (ferric uptake regulation) was first proposed for Salmonella
typhimurium (63) and first described for E. coli (108); it is now recognized as the
canonical global iron responsive regulator in bacteria. Fur is a homodimeric
transcriptional repressor whose mode of action has been reviewed extensively
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(64, 106). In brief, when cellular iron exceeds the level required for proper
function of essential iron-containing metalloenzymes, association of one Fe2+ ion
to each Fur monomer causes protein to bind a roughly 19-bp DNA motif, called
the Fur box, within the operator region of target genes. The E. coli-deduced
consensus Fur box reads as GATAATGATAATCATTATC (56), and similar
sequences are found in the operator regions of iron responsive genes in other
organisms. Typically, the Fur/DNA association blocks RNA polymerase,
repressing gene transcription. As intracellular iron levels become depleted,
Fur/Fe2+ dissociation occurs, alleviating DNA binding and derepressing iron
responsive genes. Fur is known to indirectly activate some genes, via
repression of small RNA silencing molecules (162), and direct upregulation of a
target gene has also been reported (57).

1.5.2 Alternate examples of regulatory mechanisms contributing to iron
homeostasis
Many bacteria use additional regulatory systems to respond to specific iron
ligands. In Gram-negative bacteria, the most common mechanism involves the
use of extracytoplasmic function σ factors (ECF factors), with the archetypal
example being FecI in E. coli (for a review, see (27)). This factor enables E. coli
to express genes specific for uptake of citrate-coordinated iron, genes that are
Fur repressible but require additional positive regulation for expression that
occurs only in the presence of extracellular ferric citrate. Briefly, under
nonactivating conditions (in the absence of ferric citrate), ECF factor FecI is
sequestered at the inner leaflet of the cytoplasmic membrane by
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membrane-spanning anti-σ factor FecR. When ferric citrate is imported to the
periplasm through TonB-dependent outer membrane protein FecA, with
simultaneous interaction between FecA and FecR, FecI is released into the
cytosol. FecI associates with RNA polymerase and recruits it to the operator
region of the fec operon, which encodes the proteins required for reduction of
iron in periplasmic ferric citrate and transport of Fe2+ through the cytoplasmic
membrane.
While Fur functions to repress genes required for acquisition of iron when
iron is abundant, additional regulatory measures may be necessary to help
bacteria respond to toxic intracellular accumulation of iron or iron ligands.
Recently, a heme responsive efflux system has been described for S. aureus,
and bioinformatic analysis suggests this mechanism is conserved across a
range of Gram-positive bacterial pathogens (240, 251). This involves a two
component regulatory system, HssSR, which senses intracellular heme
accumulation (HssS) and activates a transcriptional regulator (HssR) for the
expression of an ABC-type heme efflux transporter (encoded by hrtAB). In this
fashion, S. aureus can mitigate toxicity of dangerously rapid heme accumulation
following derepression of Fur regulated heme uptake genes.

1.6 Staphylococcus aureus
1.6.1 The genus Staphylococcus
The Gram-positive bacterial genus Staphylococcus comprises 49 member
species. Most are mammalian commensalists or opportunistic pathogens,
occupying niches including skin, nares, and mucosal membranes. Four species
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are of particular medical and veterinary relevance. S. saprophyticus is the
second leading cause of uncomplicated urinary tract infection (117).
S. intermedius is a leading cause of pyoderma in dogs and has become a
significant reservoir of antimicrobial resistance factors for the genus (101, 102).
S. epidermidis is a normal component of the epidermal flora of most mammals.
Its ubiquity and ability to produce a viscous, hydrophobic, extracellular
polysaccharide slime make it a leading cause of biofilm contamination of
prostheses and indwelling medical devices (68).
The most nefarious staphylococcal species is S. aureus, the causal agent
of a staggering variety of disease symptoms, ranging from cosmetic to lethal.
Following traditional diagnostics, S. aureus is distinguished from the rest of its
genus by its abundant production of secreted coagulase, an enzyme which
converts serum fibrinogen to fibrin and promotes clotting. However, some
strains of S. lugdunensis produce coagulase, as a bound form (165); and a
recent emergence of veterinary strains of coagulase-secreting non-aureus
species (213, 221) is further reducing the usefulness of this marker as a
taxonomic tool. Accuracy notwithstanding, Staphylococcus species are for the
time being classified as coagulase positive staphylococci (CPS, i.e. S. aureus)
or coagulase negative (CNS, i.e. all other staphylococci).

1.6.2 Pathogenesis
S. aureus is a frequent commensal; 30% of the American population is
asymptomatically colonized in the nostrils (92). Progression to disease is often
opportunistic on immunocompromise, injury, or other medical complications of
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the host; however, environmental strains exist that can severely infect healthy
individuals. S. aureus causes suppurative skin and subcutaneous infections,
including furunculosis, impetigo, cellulitis, mastitis, and flesh eating disease (10,
15, 42, 160, 174); respiratory infections, including nonsevere and necrotizing
forms of pneumonia (89, 212); and sepsis, which can lead to osteomyelitis,
septic arthritis, and endocarditis (62, 147, 181). Staphylococcal infection can
also result in toxic shock if the invading strain produces superantigens (169).
Severe, necrotizing disease manifestations are frequently caused by
community-acquired strains, which are often capable of infecting individuals with
no predisposing medical conditions; for recent reviews, consult (16, 53).
Systemically disseminated S. aureus can become persistent as the result
of abscession (36). Colonies seeded in organ tissues induce inflammatory
responses and attract macrophages, neutrophils, and other phagocytes.
Recruited immune cells mediate liquefaction necrosis as the host seeks to
prevent bacterial spread. Lesions containing necrotic tissue and leukocytes form
around S. aureus communities enclosed by pseudocapsules, protecting them
from the action of phagocytic immune cells. Abscesses that grow and rupture
contribute to secondary waves of sepsis.
Invasion and persistence of S. aureus in a host is dependent on a battery
of virulence factors. These include, but are not limited to, proteins and
molecules involved in: attachment (fibrinogen/fibronectin/collagen binding
proteins, polysaccharide capsule), resistance to immune cells (protein A,
complement inhibitory protein, staphylokinases, proteases), destruction of
immune cells (Panton Valentine leukocidins, phenol soluble modulins),
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subversion of immune cells (superantigens, chemotaxis inhibitory protein),
intracellular survival (catalase, carotenoid pigments), and lysis of erythrocytes
(hemolysins); for recent reviews, consult (188, 189, 255).
S. aureus coordinates expression of virulence genes such that
surface-associated factors are preferentially produced during exponential growth
phase, promoting adherence, while secreted factors are preferentially produced
in postexponential phase. This coordination is largely mediated by two
regulatory mechanisms, whose genes are encoded within the agr locus
(accessory gene regulator) and gene sarA (staphylococcal accessory regulator)
(37-39, 253). Additional mechanisms also fine tune expression of virulence
factors. The two component regulator SaeRS, for instance, is responsive to
stimuli associated with phagocytic immune cells, such as hydrogen peroxide
(85), leading to expression of secreted toxins and capsule (190, 259). As will be
discussed further below, iron limitation is also a key sensory trigger for the
expression of staphylococcal virulence factors.

1.6.3 Antibiotic resistance
Antibiotics are crucial to treatment of S. aureus disease. Alexander
Fleming originally documented staphylococcal sensitivity to what is now known
as penicillin in his hallmark 1929 report on the antibacterial properties of the
fungus Penicillium notatum (74). By the 1940’s, penicillin was being hailed as
the miracle cure to a wide range of infections. The β-lactam ring of the penicillin
molecule irreversibly binds cell wall transpeptidases (264), also known as
penicillin binding proteins (PBPs). Staphylococcal PBPs link pentapeptide side
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chains of neighbouring glycan strands, via a displacement reaction where the
L-lysine

(third position) of one side chain is bonded to the a D-alanine (fourth

position) of the other side chain via a pentaglycine bridge (87, 268). Impairing
this function disrupts the cell wall and is bactericidal. As early as 1944, penicillin
inactivation by what is now known as β-lactamase was being reported for
resistant strains of S. aureus (133). Semisynthetic penicillin derivatives
including methicillin (1959) and oxacillin (1961), unrecognizable to β-lactamase,
offered renewed hope in the battle against S. aureus. This hope proved
short-lived as resistance to these drugs readily emerged (125). This mechanism
of resistance appeared to be nondestructive toward the antibiotic (245), and was
eventually shown to be due to expression of an alternate PBP, i.e. PBP2a, with
vastly reduced affinity for β-lactams (82). The gene encoding staphylococcal
PBP2a, mecA, is localized in a mobile segment of DNA referred to as a
staphylococcal chromosome cassette (SCCmec), integrated into the S. aureus
chromosome at a site-specific location near the origin of replication (140).
Seven different SCCmec elements have been described; compositional
differences include regulatory genes for mecA, and the presence of additional
antibiotic resistance determinants (58). Methicillin resistant S. aureus (MRSA)
strains have become widely disseminated across the globe (100), and SCCmec
is increasingly documented in especially aggressive community-acquired
S. aureus infections (58).
The glycopeptide antibiotic vancomycin is the effective alternative for
treating MRSA. Glycopeptides inhibit cell wall synthesis by binding the two
terminal D-alanine residues of the pentapeptide side chains of peptidoglycan,
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blocking transglycosylation and transpeptidation reactions (211). Vancomycin
intermediate (VISA) and resistant (VRSA) strains are emerging from MRSA
lineages. Intermediacy (i.e., decreased sensitivity) results from a reworking of
the regulatory circuitry in the S. aureus cell, with increased resources going
toward cell wall thickening; this has the effect of saturating vancomycin. VISA is
also frequently associated with altered metabolism, production of protein A, and
autolysis, although the mechanisms by which these changes contributes to
vancomycin tolerance are not understood; for a more comprehensive review,
consult (118). Outright resistance to vancomycin in S. aureus is mediated by
the vanA operon, encoding for enzymes that replace terminal D-alanine residue
of peptidoglycan side chains with D-lactate (9). First reported in Japan in 1997
(115) VISA were soon documented in North America (232). The first report of
VRSA in North America occurred in Michigan in 2002, and has since reemerged
nine times in the USA (196). This threat to our last line of defense highlights the
need for research into new antistaphylococcal drugs.

1.6.4 Response to iron starvation
Iron is a cofactor of numerous proteins involved in central metabolism and
respiration. Metabolically, S. aureus responds to iron limitation by upregulating
glycolysis and downregulating the tricarboxylic acid (TCA) cycle; extreme iron
limitation results in inactivation of the electron transfer chain, leading to
fermentative growth (81). The TCA cycle involves numerous enzymes that
require iron as a cofactor (235). Glycolysis generates ATP independently of
respiration, with accumulation of pyruvate and lactate. Lactate was shown to be
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secreted by iron-starved S. aureus, resulting in acidification of the surrounding
medium; this might contribute to liberation of iron from host sequestration
proteins transferrin and lactoferrin (81).
S. aureus pathogenesis is also influenced by iron availability. Fur-Fe2+
indirectly contributes to coordinated repression of secreted hemolysins and
cytotoxins, and under sustained conditions of iron limitation upregulation of
these factors occurs. On the other hand, Fur-Fe2+ contributes to positive
regulation of immunomodulatory proteins, including superantigens, protein A,
complement inhibitory protein, and chemotaxis inhibitor (249). A fur inactivated
mutant was shown to be less virulent in a murine pneumonia model of infection
(249), suggesting that in the absence of this key regulatory protein, i.e. in a
strain that consitutively expresses an iron starvation response, virulence is
compromised due to improved clearance by immune cells despite the enhanced
cytotoxicity of the mutant.
The iron restriction response of S. aureus also involves secretion of
siderophores. A review of the scientific literature uncovers at least four named
molecules: staphyloferrin A (SA, 479 Da) (134), staphyloferrin B (SB, 449 Da)
(104), aureochelin (577 Da) (46), and staphylobactin (822 Da) (50). It should be
noted that the first three studies involved many collection-specific isolates,
whose taxonomic identification has not been corroborated using molecular
techniques. Contemporary bioinformatic interrogation has uncovered only two
potential NIS pathways (loci sfa and sbn) and one NRPS pathway (gene aus)
encoded within all sequenced S. aureus genomes. One of the NIS pathways is
also conserved broadly among CNS genomes; the NRPS pathway appears less
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frequently (principally, within Staphylococcus epidermidis). The NRPS
synthetase has been recently characterized (273, 278), and does not produce
an iron-binding metabolite (N. Magarvey, personal communication). As will be
discussed below, only the staphyloferrins appear to be bona fide S. aureus
siderophores, and SB appears thus far to be exclusive to S. aureus within the
genus.

1.6.5 S. aureus siderophores: staphyloferrin A (SA)
SA has been identified from supernatants of both S. aureus and CNS (134,
149). All sequenced staphylococcal genomes contain a highly conserved locus
comprising genes sfaABC sfaD, which encodes two NIS synthetases
(Figure 1-4A). The biosynthetic pathway for synthesis of SA was recently
characterized using recombinant, S. aureus-derived, Escherichia coli-expressed
proteins SfaD and SfaB (Figure 1-4B) (45). SfaD condenses a molecule of
citrate to the δ-amine group of D-ornithine, followed by condensation of a second
citrate to the α-amine group by SfaB to yield SA. Fe3+ coordination by SA
involves two sites provided by α-hydroxy-carboxylates derived from citrate (95),
making SA a carboxylate type siderophore. The putative function of SfaC is an
amino acid racemase, presumably for isomerization of ornithine from L- to Dforms. SfaA is predicted to be a member of the major facilitator family of efflux
pumps.
Based on sequence alignments, SfaB and SfaD cluster among B type NIS
synthetases (34). Their chemistry, however, aligns them with the A-type
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Figure 1-4: The S. aureus hts/sfa locus encodes for transport and
biosynthesis of staphyloferrin A. (A) Schematic of the hts operon, encoding
the receptor lipoprotein and permease components of an ABC transporter, and
the sfa locus, encoding enzymes involved in biosynthesis of staphyloferrin A.
Numbers refer to locus tags within the S. aureus strain Newman genome (e.g.
NWMN_2076). (B) NIS synthetases SfaD and SfaB assemble SA from two
molecules of citric acid and one molecule of D-ornithine. Proposed Fe3+coordinating atoms of SA are in red.

41

A

B

42
enzymes (i.e. specificity for citrate); they have been recently been reassigned to
a subgroup within the A-type enzymes (193).

1.6.6 S. aureus siderophores: staphyloferrin B (SB)
SB was first purified from supernatant extracts of Stapylococcus hyicus
(CNS) (104). The biochemical pathway for SB synthesis was recently
characterized using recombinant, S. aureus-derived, Escherichia coli-expressed
proteins (40). The requisite NIS synthetases include SbnC, SbnE, and SbnF,
encoded within operon sbnABCDEFGHI (siderophore biosynthesis)
(Figure 1-5A), which was previously implicated in staphylobactin production
using molecular genetics techniques (50); thus, SB and staphylobactin are one
and the same. The sbn operon has not been annotated in any sequenced CNS
genome, and a host of CNS isolates tested negative for sbn genes (50), calling
into question early reports of SB production by CNS species (104, 149); it
should be noted, however, that the S. hyicus genome is still unsequenced.
Curiously, sbn genes and SB production have also been described for two
proteobacteria: the plant pathogen Ralstonia solanacearum (21), and the heavy
metal tolerant saprotroph Cupriavidus metallidurans (124, 180).
Biosynthesis of SB can be summarized as follows (Figure 1-5B):
molecules of citrate and L-diaminopropionic acid (L-Dap) are condensed by
SbnE, forming citryl-Dap; SbnH decarboxylates the carboxyl group from the
L-Dap

moiety, creating citryl-diaminoethane (C-Dae); SbnF condenses a second

molecule of L-Dap to the remaining free prochiral carbon of the citrate moiety;
finally, SbnC condenses α-ketoglutarate to the free amine of the diaminoethane
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Figure 1-5: The S. aureus sir/sbn locus encodes for transport and
biosynthesis of staphyloferrin B. (A) Schematic of the sir operon, encoding
the receptor lipoprotein and permease components of an ABC transporter, and
the sbn operon, encoding enzymes involved in biosynthesis of staphyloferrin B.
Numbers refer to locus tags within the S. aureus strain Newman genome (e.g.
NWMN_0057). (B) NIS synthetases SbnE, SbnF, and SbnC, and
decarboxylase SbnH, assemble SB from one molecule of citric acid, one
molecule of α-ketoglutaric acid, and two molecules of L-diaminopropionic acid.
Proposed Fe3+-coordinating atoms of SB are in red.
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moiety (40). In contrast to the Sfa synthetases, phylogenetic alignments of the
Sbn synthetases agree well with their NIS activity class (34): SbnE has A-type
activity, SbnC has B-type activity, and SbnF has C-type activity. The
hexadentate coordination of Fe3+ by SB is unusual for a carboxylate-type
siderophore; in addition to typical coordination using five oxygen atoms, the sixth
coordinating atom is nitrogen from the primary amine group of the terminal
L-Dap

residue (94).

The roles of remaining Sbn proteins have not been published. Based on
bioinformatic analyses, their putative functions include a serine sulfhydrylase
(SbnA) and an ornithine cyclodeaminase (SbnB), which could work in concert to
generate L-Dap; a major facilitator family protein (SbnD), possibly for efflux of
aposiderophore; an aldolase (SbnG); and a protein of unknown function (SbnI).

1.6.7 Siderophore transport: the staphyloferrins
The ABC transporter for SA consists of lipoprotein receptor SirA and
heterodimeric permease SirBC (18, 51). The sirABC (staphylococcal iron
regulated) operon resides adjacent to the sbn operon on the S. aureus
chromosome, is preceded by a consensus Fur box, and is upregulated under
conditions of iron limitation (51). SirA has a dissociation constant for ferrated SB
in the low nanomolar range (94), and is required by S. aureus for uptake of SB
produced biologically (51) and synthetically (40). Among the CNS, only the
S. lugdunensis genome appears to encode an ABC transporter with reasonable
sequence homology to sirABC, albeit lacking the sbn operon.
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An operon encoding a putative ABC transporter preceded by a Fur box is
situated adjacent to the sfa locus in S. aureus and CNS chromosomes, making it
an attractive candidate for the genetic component involved in SA uptake. The
operon in question has been annotated htsABC (heme transport system) based
on observations that mutations in either permease gene result in an iron source
preference shift toward transferrin (231). This conclusion was derived from
limited experimental analysis and no subsequent publications have contributed
to the paradigm of HtsABC-mediated heme uptake. Furthermore, the crystal
structure of HtsA bound to SA has recently been published (95). The HtsA
binding pocket is lined with positively charged arginine residues that are quite
conducive to interacting with anionic siderophores; accommodation of
hydrophobic, planar heme molecules seems less likely, but has not been
empirically discounted.
Notably absent from sir and hts operons is a candidate ATPase gene.
Transport of both staphyloferrins is dependent on gene fhuC, which encodes the
ATPase required for transport of exogenously produced hydroxamate
siderophores via the FhuBG permease, and is transcribed from unlinked operon
fhuCBG (further described below) (237).

1.6.8 Siderophore transport: exogenous siderophores
S. aureus uses a number of hydroxamate type siderophores, including
aerobactin, ferrichrome, and desferrioxamine-B. S. aureus culture supernatants
test negative for production of this siderophore class; thus they are considered
exogenous. Transport is dependent on a permease/ATPase complex encoded
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from operon fhuCBG (227). As mentioned previously, the FhuC ATPase is
coopted by SirABC and the SA transporter (237). Two homologous receptor
lipoproteins, both genetically unlinked to fhuCBG, are involved in substrate
recognition: FhuD1 and FhuD2. The latter demonstrates higher substrate
affinity and a broader proficiency for recognition of different
hydroxamate-containing molecules (229). Hydroxamate-mediated iron
acquisition is especially relevant to medical practices, specifically with regards to
chelation therapy for treatment of iron overload disorders such as thalassemia.
A frequently administered plasma chelator is desferrioxamine-B, which is
distributed under various commercial names including DesferalTM (Novartis);
without precaution, chelation therapy may actually predispose patients to
bacterial sepsis.
S. aureus is also known to transport enterobactin as an iron ligand despite
being deficient in production of catecholate siderophores (226). Prior to the
body of work presented here, the transporter for this siderophore class had not
been identified. An attractive candidate is encoded within the sstABCD operon,
which includes genes for a dimeric permease (SstAB), an ATPase (SstC), and a
lipoprotein sharing sequence identity with bacterial receptors for iron ligands
(SstD). This operon was shown to be iron regulated in vitro and in vivo (178),
but no transported substrates were identified.

1.6.9 Heme uptake
Heme uptake by S. aureus is mediated by the Isd system of cell wall and
membrane proteins (168). Recognition of hemoproteins occurs at the outer face
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of the cell wall. In Gram-positive bacteria this is a robust yet dynamic structure
that acts as a scaffold for covalently linked surface proteins; for pathogens,
many of these are involved in recognition of and adherence to host factors.
S. aureus binds hemoglobin and hemoglobin-haptoglobin using wall-anchored
proteins IsdB (250) and IsdH (61). These extract heme through an
uncharacterized mechanism and passage it to the cytoplasmic membrane via
transfers along wall-embedded proteins IsdC and IsdA, toward membrane
protein IsdE (153, 182, 277). IsdA/B/C/H all contain NEAT (Near-iron transport)
domains: ~120 residue motifs forming eight-stranded immunoglobulin
β-sandwich folds, creating hydrophobic heme binding pockets (200). At the
cytoplasmic membrane, IsdE and IsdF form the receptor and permease
components, respectively, of the heme ABC transporter (98); within the cytosol,
iron liberation through heme degradation is mediated by monooxygenases IsdG
and IsdI (230). A model explaining the directionality of the heme relay from the
surface of the cell wall to the IsdE/F transporter has been proposed, and is
dependent on two factors: i) the localization of the heme binding proteins, which
are situated progressively closer to the cytoplasmic membrane; ii) the dynamic
rate of transfer, which is slowest at the surface of the cell wall (IsdB/H to IsdA)
but becomes progressively faster approaching the membrane (IsdC to IsdE)
(96). The contribution of Isd to virulence in animal models of infection is
significant, suggesting this system makes a major contribution to fulfilling the
nutritional iron needs of this important pathogen (201, 250). Additionally, IsdB is
one of the most abundantly expressed factors on the surface of iron-starved S.
aureus, making it an attractive candidate for antistaphylococcal vaccines (132,
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139). The importance of Isd to heme uptake should not be overstated, however;
even in its absence, S. aureus readily grows on heme as a sole iron source, and
at least one alternate uptake system has recently been uncovered
(D. E. Heinrichs and C. Chung, unpublished data).

1.6.10 Summary of S. aureus iron homeostasis genes
A review of the scientific literature pertaining to characterized S. aureus
iron homeostasis factors, combined with a swath of annotated but
uncharacterized genes from genome sequencing projects, reveals S. aureus is
exquisitely proficient at adapting to fluctuations in iron availability. Known and
putative iron homeostasis genes are summarized in Table 1-3. The redundancy
and complexity of iron acquisition mechanisms suggests that therapeutics
targeting the overall process may be of limited efficacy unless they are equally
comprehensive.

1.7 Objective and hypotheses
Septic S. aureus infection can lead to numerous debilitative and lethal
disease symptoms. Prior to the start of this study, it was known that S. aureus
uses serum transferrin as an iron source, but the mechanism or mechanisms for
this phenomenon were not described. It was also known that S. aureus
produces at least two siderophores, but their contributions to infection were
poorly characterized. During the course of this study, noteworthy publications
describing the role of catecholamine stress hormones in liberating iron from
transferrin also prompted the question of whether this interaction could
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Table 1-3: S. aureus genes with known or putative roles in iron
homeostasis
Genetic locus
Gene
(S. aureus Newman) nomenclature
NWMN_0059-0057

sirABC

NWMN_0060-0068

sbnABCDE
FGHI

NWMN_0111
NWMN_0336-0338

isdI
fepABC

NWMN_0581, 0582

fepA, fepG

NWMN_0603-0601

sitABC

NWMN_0604

feoA/sirR

NWMN_0616-618

fhuCBG

NWMN_0702-0705

sstABCD

Role

Ref.

Staphyloferrin B aka
staphylobactin transporter
(receptor lipoprotein and
heterodimeric permease
components)
Staphyloferrin B aka
staphylobactin biosynthesis

(18,
51,
94)

Heme monooxygenase
Ferrous iron ABC transporter
(receptor lipoprotein, putative
ferrous iron peroxidase,
homodimeric permease
components)
Putative iron compound ABC
transporter (receptor
lipoprotein and homodimeric
permease components)
Iron-regulated putative ABC
transporter (heterodimeric
permease components,
ATPase, and lipoprotein
receptor)
Putative iron/divalent
cation-dependent repressor
ATPase for hydroxamate/
staphyloferrin A/ staphyloferrin
B ABC transporters;
hydroxamate siderophore
transporter (heterodimeric
permease components)
Putative siderophore ABC
transporter (heterodimeric
permease components,
ATPase, and lipoprotein
receptor)

(18,
40,
50)
(230)
(23)

(24)

(114,
164)

(114,
164)
(227,
237)

(178)
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Table 1-3 continued
NWMN_0908

N/A

NWMN_1040

isdB

NWMN_1041, 1042

isdA, isdC

NWMN_1043-1045

isdDEF

NWMN_1047
NWMN_1320

isdG
brnQ3

NWMN_1406

fur

NWMN_1931

fhuD1

NWMN_2043
NWMN_2078-2076

ftnA
htsABC

NWMN_2082,
2081-2079
NWMN_2185

sfaD, sfaABC

NWMN_2262-2261
NWMN_2263-2264

hrtBA
hssRS

NWMN_2450

feoB

NWMN_2614

isdH

fhuD2

Iron-regulated putative
receptor lipoprotein
Hemoglobin/haptoglobin
binding; heme extraction
Heme transfer

Heme transporter (lipoprotein
and heterodimeric permease
components)
Heme monooxygenase
Putative branched chain amino
acid transport protein; heme
transport protein
Ferric uptake regulatory
protein
Hydroxamate siderophore
transporter (receptor
lipoprotein)
Putative bacterioferritin
Heme transporter?
Staphyloferrin A transporter
(receptor lipoprotein and
heterodimeric permease
components)
Staphyloferrin A biosynthesis
Hydroxamate siderophore
transporter (receptor
lipoprotein)
Heme transporter (efflux)
Heme-sensing two-component
regulator
Putative ferrous iron ion
transport protein
Hemoglobin/haptoglobin
binding; heme extraction

(4)
(250)
(97,
182,
203,
277)
(97,
202)
(230)
N/A

(249)
(229)

(179)
(18,
95,
231)

(18,
45)
(228)

(239)
(241)
N/A
(61)
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contribute to the growth of S. aureus in serum. The primary objective of this
study was thus to describe the ways in which S. aureus acquires transferrin iron.
Experiments were designed to test the following hypotheses:

1) Secreted siderophores and their cognate transport systems contribute to
growth of S. aureus on transferrin and to virulence.

2) Liberation of iron from transferrin following interaction with catecholamine
stress hormones provides S. aureus with iron for growth on transferrin and
contributes to virulence, and acquisition of this iron is dependent on a transport
system encoded by the sst operon.
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Chapter 2
Siderophore-mediated iron uptake in
Staphylococcus aureus

Significant portions of this chapter have been published in the following article:

Beasley, F. C., E. D. Vinés, J. C. Grigg, Q. Zheng, S. Liu, G. A. Lajoie, M. E.
Murphy, and D. E. Heinrichs (2009). Characterization of staphyloferrin A
biosynthetic and transport mutants in Staphylococcus aureus. Molecular
Microbiology, 72:947-963. This work was carried out with Dr. G. A. Lajoie’s
research group, Department of Biochemistry, University of Western Ontario, and
with Dr. M. E. Murphy’s research group, Department of Microbiology and
Immunology, University of British Columbia.

Additional portions appeared in the following articles:

Cheung, J., F. C. Beasley, S. Liu, G. A. Lajoie, and D. E. Heinrichs (2009).
Molecular characterization of staphyloferrin B biosynthesis in Staphylococcus
aureus. Molecular Microbiology, 74:594-608. This work was carried out with Dr.
G. A. Lajoie’s research group, Department of Biochemistry, University of
Western Ontario.

75
Beasley, F. C., C. Marolda, J. Cheung, S. Buac, and D. E. Heinrichs (2011).
Staphylococcus aureus transporters Hts, Sir and Sst capture iron liberated from
human transferrin by staphyloferrin A, staphyloferrin B and catecholamine stress
hormones, respectively, and contribute to virulence. Infection and Immunity, in
press.

76
2.1 Introduction
The extracellular fluid of the mammalian host is low in iron due to this
element’s poor solubility at neutral pH, and through its stringent sequestration by
host scavenging proteins. This is an important facet of innate resistance to
disease, and is described as nutritional immunity (66). The primary
sequestration factor in the serum component of plasma is the globular
glycoprotein transferrin, which has the ability to bind two atoms of ferric iron with
high affinity. In the healthy host, transferrin is perpetually undersaturated
(approximately 30% iron loaded) (16), providing a constitutive capacity for
sequestration of trace Fe3+ ions. Invasive pathogenic bacteria frequently target
host ferroproteins, including transferrin, through secretion of siderophores:
small, soluble molecules with affinities for iron approaching or exceeding the
target molecule. Siderophores are often peptidic molecules assembled by
cytosolic enzymes without the benefit of a ribosomal template.
The pathogenic bacterium Staphylococcus aureus is a leading cause of
bacteremia, as it is well adapted to overcoming iron deprivation in blood. Its
abilities to lyse erythrocytes (7, 8, 13, 21, 26, 28, 37) and capture hemoglobin
iron through the Isd system of cell wall-anchored and transmembrane proteins
(32, 45, 48, 52, 65) are well described, and are prominently touted as the
strategy through which S. aureus acquires iron during sepsis (62). The ability to
grow on transferrin as an iron source has also been noted (44, 51, 55), but
studies have contributed little toward a mechanistic explanation of this process,
and have not evaluated any contribution to virulence.
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At the commencement of this study, S. aureus had previously been shown,
using molecular genetic techniques, to produce at least one structurally
uncharacterized siderophore, termed staphylobactin. This metabolite’s
production was a function of the sbnABCDEFGHI operon (staphylobactin or
siderophore biosynthesis) (Figure 1-5A), which is induced under conditions of
iron limitation (17). Uptake of Fe-staphylobactin was shown to be a function of
the SirABC (staphylococal iron regulated) transporter, whose operon is situated
adjacent to sbn on the S. aureus chromosome (18, 35).
The sbn operon encodes three NIS synthetases: SbnC, SbnE, and SbnF
(12). Chromosomal inactivation of a synthetase was reported to curtail growth
of S. aureus under conditions of severe iron chelation (17). S. aureus genome
sequencing projects subsequently uncovered two alternate loci from sbn which,
according to annotation, could be involved in production of nonribosomal
peptides. One encodes a recently characterized multidomain NRPS (69), which
does not produce metabolites with iron coordination capacities (N. Magarvey,
personal communication). Annotation of the third locus (Figure 1-4A) described
it to encode two NIS synthetases. Curiously, this locus is chromosomally
adjacent to an operon encoding an ABC transporter implicated in heme
acquisition based on limited evidence (62). Concurrently to this study, the NIS
locus was annotated by another research group as sfna (staphyloferrin A
biosynthesis) (14). It is hereby rebranded sfa for compliance with proper
protocols in bacterial genetic nomenclature.
In this study, mutagenesis was performed to eliminate loci sbn, sfa, sir, and
hts from the staphylococcal chromosome in an attempt to categorize the entire

78
complement of S. aureus siderophore biosynthesis/transport systems, as well as
to dissect their individual and combined contributions toward growth of S. aureus
in iron-restricted media such as serum, and to assess their roles in virulence in
murine infection models.

2.2 Materials and methods
2.2.1 Bacterial growth conditions
All bacteria were cultured at 37 °C unless otherwise indicated. Bacterial
strains used are summarized in Table 2-1. Escherichia coli was grown in Difco
Luria-Bertani broth (BD Diagnostics). Staphylococcus epidermidis was grown in
Gibco RPMI Medium 1640 [+] L-glutamine [+] 25 mM Hepes (Invitrogen)
enriched with 1% w/v Difco casamino acids (CAA-RPMI) (Becton, Dickinson and
Co.). For genetic manipulations, S. aureus was grown in Difco tryptic soy broth
(TSB) (Becton, Dickinson and Co.). For subsequent experiments, S. aureus
strains were grown, as specified below, in: Tris-minimal succinate broth (TMS)
(61); TMS chelated with 2,2’-dipyridyl (Sigma-Aldrich) or
ethylenediaminedi-N,N’-bis(2-hydroxyphenylacetic acid) (EDDHA) (LGC
Standards GmbH); a 40:60 mixture of TMS and horse serum (Sigma-Aldrich)
that was previously incubated at 55 °C for 2 h to inactivate complement
(HoS-TMS); TMS treated for 24 h at 4 °C with 10% w/v Chelex-100 resin
(Bio-Rad) prior to addition of post-autoclaving nutrients (C-TMS); or C-TMS
amended with 10 to 20 µM human apotransferrin or holotransferrin
(approximately 60% iron saturated) (Sigma-Aldrich). For iron repletion of
restricted growth media, FeCl3 was added to a final concentration of 50 to
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100 µM. Solid media were prepared by incorporating 1.5% w/v low iron Difco
Bacto agar (Becton, Dickinson and Co.) to specified media.
For selection of plasmids and recombinant alleles, antibiotics (BioShop,
Burlington, Ontario) were added to media at the following concentrations:
ampicillin (100 μg/mL), tetracycline (4 µg/mL), kanamycin (50 µg/mL), neomycin
(50 µg/mL), chloramphenicol (30 µg/mL for E. coli and 5 μg/mL for
Staphylococcus sp.), erythromycin (300 µg/mL for E. coli and 3 μg/mL for
S. aureus), and lincomycin (20 μg/mL). All media were made with water purified
through a Milli-Q water purification system (Millipore). All glassware was treated
overnight in 0.1 M HCl and rinsed thoroughly in Millipore water to remove
residual contaminating iron.

2.2.2 General molecular genetic methodologies
Purification of plasmid DNA was performed using a QIAPrep Mini-spin kit
(QIAgen) according to the manufacturer’s instructions. For preparations from
Staphylococcus, 10 µg lysostaphin (Sigma-Aldrich) and a 37 °C incubation were
incorporated into the P1 buffer treatment until cell lysis occurred. Plasmids used
are summarized in table 2-1. Purification of S. aureus chromosomal DNA was
performed as previously described (60).
Polymerase chain reaction (PCR) was performed using Taq polymerase
(New England Biolabs) or Pwo polymerase (Roche Diagnostics) according to
manufacturers’ instructions. Primers were designed using Primer3 software
(Whitehead Institute and Howard Hughes Medical Institute). Primers are
summarized in table 2-1. Restriction digests were performed using enzymes
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Table 2-1: Bacterial strains, plasmids, and oligonucleotides used in this
study
Description

Ref.

E. coli strains
DH5α

F- ϕ80lacZΔM15 Δ(lacZYA-argF)U169
Invitrogen
recA1 endA1 hsdR17(rk- mk+) phoA supE44
thi-1 gyrA96 relA1 ʎ-

S. aureus
strains
RN4220

rk- mk+; accepts foreign DNA

(41)

RN6390

Prophage-cured laboratory strain

(56)

Newman

Wild-type clinical isolate

(22)

H306

RN6390 sirA::Km

(18)

H672

(17)

H1448

RN6390 sbnF::Km (originally described as
sbnE::Km)
RN6390 ΔhtsABC::Tc

H1480

RN6390 sirA::Km ΔhtsABC::Tc

This study; (6)

H803

Newman sirA::Km

(18)

H1262

Newman ΔhtsABC::Tc

This study; (6)

H1497

Newman sirA::Km ΔhtsABC::Tc

This study; (6)

H1321

RN6390 ΔsbnABCDEFGHI::Tc

This study; (6)

H1661

RN6390 ΔsfaABCsfaD::Km

This study; (6)

H1649

This study; (6)

H1331

RN6390 ΔsbnABCDEFGHI::Tc
ΔsfaABCsfaD::Km
Newman ΔsbnABCDEFGHI::Tc

H1665

Newman ΔsfaABCsfaD::Km

This study; (6)

H1666

Newman ΔsbnABCDEFGHI::Tc
ΔsfaABCsfaD::Km

This study; (6)

This study; (6)

This study; (6)
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Table 2-1 continued
H1074

Newman ΔfhuCBG::Em

(63)

H1112

Newman fhuG::Tn917

(60)

AD25

Canadian atopic dermatitis isolate

MSSA476

American osteomyelitis/sepsis methicillinsensitive isolate
American septic arthritis methicillin-resistant
isolate
American osteomyelitis isolate

M. McGavin
collection
(36)

MW2
UAMS-1

(3)
(27)

American community-acquired necrotizing
fasciitis isolate

(50)

846-1

Plasmid-cured type strain

D. Mack

1457-M10

Biofilm-deficient 846-1 mutant (icaA::Tn917;
EmR)

(20)

pBC SK(+)

E. coli cloning vector; CmR

Stratagene

pUC19

E. coli cloning vector; ApR

(70)

pLI50

E. coli/S. aureus shuttle vector; ApR/CmR

Novagen

pDG1513

pMTL22 derivative carrying tetracycline
resistance cassette; ApR
BluescriptKS+ derivative carrying kanamycin
resistance cassette; ApR
E. coli/S. aureus shuttle and temperaturesensitive suicide vector; EmR
pAUL-A derivative carrying
ΔsbnABCDEFGHI::Tc allele; TcR EmR
pAUL-A derivative carrying ΔhtsABC::Tc
allele; TcR EmR
pLI50 derivative carrying fhuC; CmR

(33)

USA300 LAC
S. epidermidis
strains

Plasmids

pDG780
pAUL-A
pFB10
pEV83
pFhuC

(33)
(10)
(6)
(6)
(63)
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Table 2-1 continued
This study;
(6)
This study;
(6)
This study;
(6)
This study;
(6)

pALC2073

pLI50 derivative carrying S. aureus
sfaABCsfaD; CmR
pLI50 derivative carrying S. epidermidis
sfaABCsfaD; CmR
pLI50 derivative carrying S. saprophyticus
sfaABCsfaD; CmR
pEV90 derivative carrying
ΔsfaABCsfaD::Km allele with loss of
function frameshift mutation in
Gram-positive replicase gene repB; CmR
E. coli/S. aureus shuttle vector; ApR/CmR

pSirABC

pBC SK(+) derivative carrying sirABC; CmR

(18)

pFB54

pALC2073 derivative carrying S. aureus
fhuC/sirABC transcriptional fusion; CmR
pALC2073 derivative carrying S. aureus
fhuC[K42N] (loss of function Walker motif
missense mutation)/sirABC transcriptional
fusion; CmR

This study

pEV90
pEV95
pEV96
pFB50

pFB57

(5)

This study

Oligonucleotides*
hts5’F-SacI
hts5’R-BamHI
hts3’F-BamHI
hts3’R-XbaI
sbn5’F-KpnI
sbn5’R-SmaI
sbn3’F-SmaI
sbn3’R-XbaI
sfaSA5’
sfaSA3’
sfaSE5’-EcoRI
sfaSE3’-SmaI

5’ TGAGCTCTGCGATTACATTGGAGGCTG 3’
5’ GGGATCCGATAACAATTATCATTGTCAAG 3’
Generation of S. aureus ΔhtsABC::Tc allele, 5’ arm
5’ CGGATCCCTAACATATGATTAGAGTTTAAAA 3’
5’ GTCTAGAGGTCTCATAACCGGTCTAAAAA 3’
Generation of S. aureus ΔhtsABC::Tc allele, 3’ arm
5’ TTGCGCGGTACCAGGAAGCGCTTTTGATTGAA 3’
5’ TTGTGTCCCGGGATGACTGACCCTTTCGCATC 3’
Generation of ΔsbnABCDEFGHI::Tc allele, 5’ arm
5’ TTGCGCCCCGGGCGCAATTGGAAGCAGTTTT 3’
5’ TTGCGCTCTAGAGATGCCAATACGATGACAGG 3’
Generation of ΔsbnABCDEFGHI::Tc allele, 3’ arm
5’ GTATAGATTGTATTTAATAAGTTAATGTAATCC 3’
5’ TGCAAACGATATGTAGTATAACTTGTCAAC 3’
Cloning of S. aureus sfaABCsfaD
5’ ATATGAATTCTTGAGCATGACGCTCAAGTGC 3’
5’ ATATCCCGGGGAGACGGTGCGTTGAGTTAAAG
G 3’
Cloning of S. epidermidis sfaABCsfaD
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Table 2-1 continued
sfaSS5’-BamHI
sfaSS3’-SmaI
fhuC5’-SphI
fhuC3’-PstI

sfaD-RT-PCR-F
sfaD-RT-PCR-R
sfaA-RT-PCR-F
sfaA-RT-PCR-R
htsA-RT-PCR-F
htsA-RT-PCR-R
gyrB-RT-PCR-F
gyrB-RT-PCR-R

5’ TATAGGATCCATCTATTTTTACTTTAATCTAGCGG
ACGG 3’
5’ TATACCCGGGCTATGTTTCATCGTTTTCCCTCCT
TAG 3’
Cloning of S. saprophyticus sfaABCsfaD
5’ TTGATAGCATGCCATGACAAATCGAGCTATCC 3’
5’ TTGATACTGCAGTTAAGAATAAGCTCTGCGAC
A 3’
Cloning of S. aureus fhuC or fhuC[K42N] to make a
transcriptional fusion with sirABC
5’ CCTCTAATGCAATGCCATATTTA 3’
5’ ACAATGAATCACCTATCGTGACA 3’
5’ AGTCTATCATGCGCCAACAAC 3’
5’ AACCTGTCGCCATAATCAATAA 3’
5’ TTTAAATCCAGAGCGTATGATCA 3’
5’ CAGAAGAAATTAAGCCACGAGAT 3’
5’ ATAATTATGGTGCTGGGCAAAT 3’
5’ AACCAGCTAATGCTTCATCGATA 3’
Real time PCR primers (gyrase B used as internal
―housekeeping gene‖ reference)

*underlined sequences in oligonucleotides denote restriction sites
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purchased from New England Biolabs and Roche Diagnostics according to
manufacturers’ instructions. Blunting reactions were performed using Klenow
fragment (Roche Diagnostics) according to manufacturer’s instructions. Linear
DNA fragments were purified directly from restriction reactions or following
resolution through agarose gels using the QIAQuick PCR purification kit
(QIAgen) according to the manufacturer’s instructions. Ligation reactions were
performed using T4 DNA ligase (New England Biolabs). Sequencing reactions
were performed by the London Regional Genomics Centre.

2.2.3 Cloning and mutagenesis of S. aureus
Plasmids generated and used in this study are summarized in Table 2-1.
Allelic replacement was used to delete the majority of operons sbnABCDEFGHI
and htsABC, and locus sfaABCsfaD, from the chromosome of S. aureus. The
ΔsbnABCDEFGHI::Tc knockout allele contained arms homologous to sbnA and
to noncoding DNA downstream of sbnI. The arms were cloned sequentially to
plasmid pBC SK(+), XbaI to SmaI and KpnI to SmaI. A tetracycline resistance
cassette was excised from plasmid pDG1513 with restriction enzymes SspI and
Nae, blunted with Klenow fragment, and cloned between the arms at the SmaI
site. The knockout allele was excised and cloned to the temperature sensitive
E. coli/S. aureus shuttle vector pAUL-A, KpnI to XbaI, creating plasmid pFB10.
This was electroporated into S. aureus strain RN6390 after passaging through
strain RN4220. The RN6390 recipient was grown in TSB to mid-log phase at
30 °C, shifted to 42 °C for 16 h, then plated to TSB agar plates containing
kanamycin and neomycin. Resistant clones were screened for sensitivity to
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erythromycin, indicating a loss of pAUL-A backbone DNA following integration of
the knockout allele to the chromosome via homologous recombination on either
side of the tetracycline resistance cassette.
To generate the ΔhtsABC::Tc allele, 5’ and 3’ arms targeting the noncoding
region flanking the operon were PCR amplified and sequentially cloned to
plasmid pUC19, SacI to BamHI then BamHI to XbaI. A tetracycline resistance
cassette was excised from plasmid pDG1513 with restriction enzymes BamHI
and BglII and ligated between the flanking arms at the BamHI site. The
ΔhtsABC::Tc allele was excised and cloned to plasmid pAUL-A, SacI to XbaI,
generating plasmid pEV83. Subsequent passaging into S. aureus and
integration into the chromosome was performed as described above for sbn
mutagenesis.
To generate the ΔsfaABCsfaD::Km knockout allele, the sfa cluster was
PCR amplified, restricted at a SacI site downstream of the sfaD stop codon, and
cloned SacI to SmaI to the E. coli/S. aureus shuttle vector pLI50, making
plasmid pEV90. Plasmid pEV90 was digested with SpeI and EcoRV internally to
sfaD and sfaC, excising most of the gene cluster, which was replaced by the
XbaI/PvuII excised kanamycin resistance cassette from plasmid pDG780. NsiI
restriction followed by Klenow fragment fill-in introduced a frameshift mutation
into the repB gene of the pLI50 backbone, inactivating the Gram positive
replicase protein, and creating plasmid pFB50. Plasmid pFB50 was
electroporated to S. aureus strain RN4220 carrying unmodified pLI50, enabling
propagation of pFB50 by complementation in trans with wild type RepB.
Plasmid pFB50 was transduced to S. aureus strain RN6390 using phage 80α as
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described below, and recipient culture was plated to TSB agar containing
kanamycin and neomycin. Resistant clones were screened for sensitivity to
chloramphenicol, indicating a loss of pLI50 backbone DNA following integration
of the knockout allele to the chromosome via homologous recombination on
either side of the kanamycin resistance cassette.
Mobilization of S. aureus plasmids and mutated chromosomal alleles
between strains was performed using transducing ϕ80α as follows. Cultures of
donor strains were grown overnight in TSB then diluted 1:2 into fresh TSB
containing 2.5 mM CaCl2. Cultures were incubated for 10 min then infected with
>108 plaque forming units of bacteriophage. Cultures were incubated for 15 min
then added to 20 mL fresh TSB containing 2.5 mM CaCl2. Cultures were
incubated with gentle shaking through several rounds of bacterial replication
followed by culture lysis. Debris was pelleted by centrifugation at 3 krpm and
supernatant was passaged through a 0.2 µM filter. Lysate was serially diluted in
10-fold increments in bacteriophage buffer (50 mM Tris pH 7.8, 0.1 M NaCl,
1 mM MgSO4, 4 mM CaCl2) and 100 µL aliquots were combined with 100 µL
aliquots of recipient strains grown to early exponential phase in TSB containing
2.5 mM CaCl2. Following a 20 min incubation at 37 oC, recipient/lysate mixtures
were spiked with 50 mM sodium citrate and plated on selective TSB agar.

2.2.4 Real time PCR
S. aureus cells grown to stationary phase in TMS with 100 µM 2,2-dipyridyl
were washed twice in saline buffer and diluted 1:100 into HoS-TMS. Cultures
were grown at 37 °C with ample aeration to mid-logarithmic phase (OD600 ~ 1.0),
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then partitioned into two aliquots of equal volume. One aliquot from the pair was
spiked with 50 µM FeCl3. Growth was allowed to resume for 1 h, then 20 mL
culture aliquots normalized to OD600 of 1.0 were pelleted by centrifugation at
4 °C. RNA was extracted using RNeasy kits (QIAgen) according to the
manufacturer’s instructions. RNA extraction was preceded by mechanical cell
disruption through two 20 s treatments in 500 µL RLT buffer in a FastProtein
Blue #6550-500 tube using a FastPrep disruptor at a setting of 5.0 (Qbiogene).
100 ng RNA was reverse transcribed and PCR amplified using the
iScriptTM One-Step RT-PCR kit with SYBR Green (Bio-Rad), as directed, with
primers listed in Table 2-1, in a Rotor-Gene 6000 Real Time Analyzer (Corbett
Life Sciences). Quantification relative to housekeeping gene gyrB was
performed using the comparative CT method according to User Bulletin #2: ABI
Prism 7700 Sequence Detection System (2001) (Applied Biosystems). For each
representative RNA extraction, one-step reactions were performed in triplicate.

2.2.5 Heterologous expression of SirABC in S. epidermidis
In previous attempts to make a sirABC-expressing vector, numerous
attempts to clone the operon into S. epidermidis-compatible shuttle vectors
along with its native operator region, or under control of an inducible
vector-borne promoter, proved unsuccessful. Thus, the promoterless sirABC
operon from the previously constructed pSirABC (18) was excised using
restriction enzymes SacI and PstI and cloned to pALC2073, replacing the tetR/O
region. To enable expression of sirABC, and to provide the potentially requisite
S. aureus FhuC ATPase for proper SirABC function (63), fhuC and its operator
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region were PCR amplified from the S. aureus chromosome with engineered
flanking PstI and SphI restriction sites and cloned to the pALC2073 derivative
within the PstI located at the 5’ end of sirABC. The resulting plasmid, pFB54,
thus carried a transcriptional fusion of sirABC to fhuC under control of the fhuC
operator. Alternately, a nonfunctional fhuC allele harbouring a K42N Walker A
domain mutation, characterized previously (63), was cloned in similar fashion to
create a transcriptional fusion for plasmid pFB57. After passaging through
S. aureus RN4220, pFB54 and pFB57 were transformed to sucrose-competent
S. epidermidis 1457-M10 via electroporation.

2.2.6 Complementation of the sfa deletion mutation
The ΔsfaABCsfaD::Km mutation in the S. aureus RN6390 chromosome
was complemented using plasmid pEV90, described above. Additionally,
complementation was performed using the annotated sfaABCsfaD locus from
S. epidermidis. This was PCR amplified and cloned to pLI50 between restriction
sites EcoRI and SmaI.

2.2.7 Bacterial growth curves
S. aureus cells grown to stationary phase in TMS with 100 µM 2,2-dipyridyl
were washed twice in saline buffer and diluted 1:100 into HoS-TMS broth.
Culture medium was left unamended (iron deplete) or amended with 50 µM
FeCl3 (iron replete). Cultures were grown at under constant medium amplitude
shaking in a Bioscreen C machine (Oy Growth Curves Ab Ltd.), with absorbance
measured at 600 nm.
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2.2.8 Concentration of siderophore from culture supernatants
S. aureus cells grown to stationary phase in TMS with 100 µM 2,2-dipyridyl
were washed twice in saline buffer and diluted 1:100 into TMS containing
250 nM EDDHA in acid washed glass flasks with generous head space.
Cultures were grown to the postexponential phase (approximately 30 h).
Culture aliquots were extracted and cells were removed by centrifugation at
5 krpm. Supernatants were frozen at -80 °C and liquid was removed under a
vacuum at -80 °C. Lyophilized extract was resuspended in 1/5 the original
supernatant volume in methanol with gentle shaking for 30 min at room
temperature. Insoluble debris was removed by ultracentrifugation. Methanol
was removed by rotary evaporation and residue was redissolved in 1/20 the
original supernatant volume in water. Further purification included passage
across an amberlite IRA-402 (Fluka) anion exchange column. The column was
washed extensively with water before elution with 3 M formic acid. Siderophore
active fractions (see next section) were subjected to a desalting step using a
C18 cartridge (Applied Separations).

2.2.9 Chrome-azurol S assay for siderophore activity
Siderophore activity of solutions was measured using the chrome azurol S
(CAS) assay (59). Dilutions of sample were mixed with equal volumes of CAS
shuttle solution and incubated in darkness at room temperature with gentle
shaking for 45 min. With an empty cuvette serving as the blank, siderophore
units were calculated as follows:
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100 x dilution factor x (A630 of control solution – A630 of sample)
A630 of control solution

For describing siderophore activity of raw culture supernatants,
siderophore units were normalized to a culture OD600 of 1.0.

2.2.10 Mass spectrometry
Spectrometric analyses were performed by the staff of the laboratory of
G. A. Lajoie (Department of Biochemistry, University of Western Ontario).
Eluent desalted across a C18 cartridge (see above) was dried and re-dissolved
in 100 μl of water containing 100 mM EDTA and 0.1% formic acid. Addition of
EDTA greatly increased the detection level of metabolites, since contaminating
metal ions have been shown to interfere with detection (46). 20 µL was injected
into a liquid chromatography mass spectrometry/tandem mass spectrometry
(LC-MS/MS) system comprised of a Waters CapLC with a Phenomenex Jupiter
Proteo 90 A column (150 x 1.0 mm), 4 μm coupled to a Micromass Q-TOF micro
mass spectrometer (Waters). Separation was carried out at a flow rate of
40 µl/min with a gradient starting at 0% B for 4 min, ramping to 15% B in 4 min,
then ramping to 90% B in 4 min and holding for 4 min. Solvent A was water and
solvent B was 95% acetonitrile, both with 0.1% formic acid. LC-MS was
performed with electrospray in negative ion mode with a scan range
200-950 m/z. Collision-induced dissociation was performed with a mass range
60-500 m/z using Argon as collision gas. Variable collision energy of 20-30 V
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was applied to obtain an informative fragmentation spectrum. Data were
analyzed using MassLynx 4.0 (Micromass).

2.2.11 Siderophore plate bioassays
Staphylococcal cells were successively cultured in TMS then TMS
containing 100 µM 2’2-dipyridyl (S. aureus) or CAA-RPMI then CAA-RPMI
containing 100 µM 2’2-dipyridyl (S. epidermidis). Cells were pelleted and
washed twice in saline buffer. Cells were seeded into cooled molten agar media
to densities of 5 x 108 CFU/mL. Media used included TMS agar containing
10 µM EDDHA (S. aureus) and CAA-RPMI agar containing 5 µM EDDHA
(S. epidermidis). Media were dispensed into Petri dishes in precise 25 mL
aliquots. Plates were allowed to gel and dry in the dark at room temperature for
approximately 6 h. Sterile 6 mm diameter paper discs (Becton, Dickinson and
Co.) impregnated with up to 20 µL of an iron-ligand solution were placed on the
surface of the agar. Growth promotion was measured as the diameter of a halo
of bacterial colonies forming around the paper disc after 36 h of growth.

2.2.12 Mouse models of S. aureus infection
Mouse sepsis experiments were performed as follows. S. aureus cultures
were grown overnight in TMS or TSB, pelleted by centrifugation, washed twice
in saline buffer, and diluted 1:50 (OD600 = 1.0) into fresh TMS or TSB. These
cultures were grown to midexponential phase (OD600 ~ 1 to 3), pelleted by
centrifugation, washed twice in saline buffer, and resuspended in saline buffer.
After a 30 min equilibration incubation at room temperature, cells were diluted to
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an optical density correlating to a predetermined CFU/mL titre. Seven week old
female BALB/c mice (Charles River Laboratories or Jackson Laboratories)
housed in microisolator cages (maximum four per cage) were infected via tail
vein injection with 100 µL bacterial suspension containing 0.1 to 5 x 107 CFU.
Mice were euthanized if the infection rendered them immobilized, incapable of
eating or drinking, or if they lost greater than 25% body mass. Four days post
infection, mice were euthanized via intraperitoneal injection of sodium
pentobarbitol. During dissection, organs including hearts, kidneys (as a pair),
livers, spleens, and/or lungs (as a pair) were removed and placed in sterile
phosphate-buffered solution containing 0.1% v/v Tween-20. Organs were
homogenized. Homogenates were serially diluted and four 10 µL aliquots were
spotted onto TSB agar plates. After 24 h growth, CFU were counted and
bacterial loads (log CFU/organ or organ pair) were calculated. The Student’s
t-test was used to calculate statistical significance for differences in data sets.
Bacteria were cultured and prepared in a similar fashion for skin lesion
models of infection. Seven week old male BALB/c or nude SKH-1 mice were
purchased from Charles River. The backs of BALB/c mice (Charles River
Laboratories) were shaved 24 h prior to infection. Mice were injected
subcutaneously on the right flank with 200 µL bacterial suspension containing
5 x 108 CFU. Lesions were measured at 24 h intervals until sacrifice using
electronic calipers. Lesion area was calculated as 0.5 x length x width x π (47).
The Student’s unpaired t-test was used to calculate statistical significance for
differences in data sets.
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2.3 Results
2.3.1 A Δsbn mutant secretes siderophore(s)
It was previously reported that a S. aureus strain RN6390 staphylobactin
synthetase mutant (sbnF::Km, erroneously described as sbnE::Km in the report)
was severely impaired for growth in chelated basal medium (TMS containing
10 µM EDDHA). This defect was attributed to lack of siderophore production
(17). Attempts were made to reproduce this experiment using an
operon-spanning Δsbn deletion mutant, also in S. aureus strain RN6390. These
proved unsuccessful as even the wild type parental strain was severely growth
impaired in this medium (data not shown). As EDDHA is a very strong iron
chelator, the assay was repeated using a lower concentration sufficient to create
conditions of moderate iron restriction (0.25 µM).
In this revised growth medium, both the sbnF::Km and Δsbn mutants grew
equally capably as their isogenic wild type parent (Figure 2-1A). Culture
supernatant siderophore activity was sampled at three intervals (10, 30, and
60 h). While the sbnF::Km mutant was moderately but significantly impaired for
siderophore output at all three sampling times, it nevertheless secreted
quantifiable amounts of (an) alternate iron chelator(s), while its Δsbn counterpart
performed at a level statistically comparable to the wild type parent
(Figure 2-1B). From this pilot study, it was concluded that at least one alternate
genetic locus to the sbn operon mediates S. aureus siderophore production.
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Figure 2-1: S. aureus sbn operon mutants produce siderophore(s).
(A) S. aureus RN6390 derivatives with mutations in the sbn operon (sbnF::Km
and Δsbn) were grown in low iron medium. (B) Mutants and wild type alike
secreted iron-chelating metabolite(s) into the supernatant, detected using the
CAS assay at sampling times of 10, 30, and 60 hours. Error bars represent
standard deviation from the mean. Statistical differences between mutants and
the wild type parental strain were calculated using the Student’s unpaired t-test
(* = P < 0.01).
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2.3.2 sfa encodes putative NIS synthetases and is conserved among
pathogenic staphylococci
The sfa locus is conserved across all sequenced Staphylococcus
genomes, as is an adjacently transcribed operon encoding a putative iron
compound ABC transporter, htsABC (Figure 1-4A). BLAST searches uncovered
similarities between predicted sfa and sbn siderophore synthetases, and with
aerobactin synthetase genes from E. coli, suggesting the sfaABCsfaD locus may
be involved in production of a staphylococcal siderophore (Table 2-2).

2.3.3 sfa is repressed by iron via Fur
Previous work demonstrated that the sbn operon is expressed under
conditions of iron restriction in a Fur/Fe-dependent fashion (17); it was of
interest to determine if sfa would be regulated in such a fashion as well. The
intergenic region between divergently transcribed sfaA and sfaD as well as the
operator region of htsABC contain sequence motifs resembling canonical Fur
protein recognition sites (42) (Figure 2-2), suggesting these genes play roles in
the iron deprivation response of staphylococci. Real-time PCR analysis
confirmed that, consistent with this prediction, all three transcripts are
upregulated in an iron deprivation-dependent fashion, i.e. they are repressed by
iron saturation of the culture medium, but continue to be readily expressed
regardless of iron availability in a fur-inactivated mutant (Figure 2-3).
Having established the sfa locus is a component of the Fur-mediated iron
deprivation transcriptional response, and that it encodes putative siderophore
synthetases, a Δsfa mutant knockout allele was constructed in the S. aureus
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Table 2-2: BLAST matches to putative S. aureus siderophore
biosynthesis/transport proteins
Identity

Similarity

(%)

(%)

S.epidermidis
RP62A

75

91

1e167

S.saprophyticus
ATCC15305

62

81

1e131

S.epidermidis
RP62A

65

79

0.0

Predicted
siderophore
biosynthesis
protein (SSP0707)

S.saprophyticus
ATCC15305

60

78

0.0

SbnC

S. aureus
Newman

24

43

7e16

Aerobactin
biosynthesis
protein IucC
Predicted amino
acid racemase
(SERP1778)

E. coli
APEC O1

22

42

2e6

S. epidermidis
RP62A

64

82

3e126

Predicted amino
acid racemase
(SSP0708)

S.saprophyticus
ATCC15305

60

81

8e122

Protein/ Match
locus
(strain
Newman
genome)

Bacterium

SfaA/
2081

Predicted major
facilitator family
transporter
(SERP1780)
Predicted major
facilitator family
transporter
(SSP0706)
Predicted
siderophore
biosynthesis
protein
(SERP1779)

SfaB/
2080

SfaC/
2079

E
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Table 2-2 continued
SfaD/
2082

HtsA/
2078

HtsB/
2077

HtsC/
2076

Predicted
siderophore
biosynthesis
protein
(SERP1781)
Predicted
siderophore
biosynthesis
protein (SSP0705)
SbnE

S. epidermidis
RP62A

60

76

0.0

S.saprophyticus
ATCC15305

54

70

0.0

S. aureus
Newman

24

41

4e21

Aerobactin
biosynthesis
protein IucC

E. coli
APEC O1

23

43

2e12

Predicted iron
compound-binding
protein
(SERP1777)

S. epidermidis
RP62A

73

85

8e129

Predicted iron
compound-binding
protein (SSP0709)

S.saprophyticus
ATCC15305

63

79

4e105

Predicted iron
compound
transporter,
permease
component
(SERP1776)
Predicted
siderophore
transport system,
permease
component
(SSP0710)

S. epidermidis
RP62A

73

90

2e132

S.saprophyticus
ATCC15305

69

84

6e119

Predicted iron
compound
transporter
permease
component
(SERP1775)

S. epidermidis
RP62A

76

91

2e119

Predicted
siderophore
transport system,
permease
component
(SSP0711)

S.saprophyticus
ATCC15305

68

87

9e109

99

Figure 2-2: Operator regions of the sfa/hts locus. Nucleotide sequences of
the operator regions of the htsABC operon and the sfaABCsfaD locus.
Predicted start codons are in bold; predicted Shine-Dalgarno sequences (S.D.)
are underlined; putative Fur box sequences are between two lines. Nucleotide
positions along the S. aureus strain Newman chromosome are indicated.
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Figure 2-3: Expression of sfa and hts genes is regulated by Fur-Fe.
Regulation of sfaD, sfaA, and htsA by iron and Fur in S. aureus strain Newman.
Real-time PCR of wild type and a fur inactivated mutant demonstrates
upregulation in the absence of iron, or in the absence of Fur protein when iron is
present. Error bars represent standard deviation from the mean (n = 3). Strains
were grown in HoS-TMS medium. + Fe denotes cultures spiked with
100 µM FeCl3 for one hour at mid-log phase prior to cell harvesting.
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chromosome for the purpose of characterizing its contribution to siderophore
iron uptake. When combined with the Δsbn mutation, this resulted in a
S. aureus strain devoid of NIS synthetases.

2.3.4 The sbn operon mediates SB biosynthesis; staphylobactin is SB
Low iron culture supernatant concentrates of the S. aureus strain RN6390
Δsbn Δsfa mutant and its isogenic Δsfa counterpart were examined for
differences in mass ion composition, especially for those correlating to the
known structures of staphylococcal siderophores (i.e. SA and SB), using
LC-ESI-MS. Shown in Figure 2-4 are the selected ion chromatograms and
mass spectra for the two samples. A peak with m/z of 447.14, corresponding to
the published structure of SB (34), eluted from the Δsfa preparation at 5.09 min
(Figure 2-4A), while no peak for that mass above background levels of detection
was observed for the Δsfa Δsbn preparation (Figure 2-4B). To further confirm
that the peak at 447.14 m/z represented SB, LC-MS/MS with collision-induced
dissociation (CID) was carried out, generating a fragmentation pattern consistent
with the chemical structure of SB (data not shown).

2.3.5 The sfa locus mediates SA biosynthesis
LC-ESI-MS was also used to determine the molecular identity of the
Sfa-synthesized metabolite. Low iron culture supernatant concentrates of the
S. aureus strain RN6390 Δsbn Δsfa mutant and its isogenic Δsbn counterpart
were examined for differences in mass ion composition. Shown in Figure 2-5
are the selected ion chromatograms and mass spectra for the two samples. A

104

Figure 2-4. Identification of staphyloferrin B production by S. aureus
strain RN6390. (A) Concentrated spent culture supernatant from the
iron-starved Δsfa mutant was subjected to LC-ESI-MS analysis. Shown is the
selected ion chromatogram for the ion at m/z 447.1 from LC-ESI-MS, with the
ESI-MS spectrum of that peak displayed in the inset. (B) Similar analysis to
(A), using concentrated spent culture supernatant from the iron-starved Δsbn
Δsfa mutant.
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Figure 2-5. Identification of staphyloferrin A production by S. aureus
strain RN6390. (A) Concentrated spent culture supernatant from the
iron-starved Δsbn mutant was subjected to LC-ESI-MS analysis. Shown is the
selected ion chromatogram for the ion at m/z 479.1 from LC-ESI-MS, with the
ESI-MS spectrum of that peak displayed in the inset. (B) Similar analysis to
(A), using concentrated spent culture supernatant from the iron-starved Δsbn
Δsfa mutant.
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peak with m/z of 479.11, corresponding to the published structure of SA (39),
eluted from the Δsbn preparation at 11.27 min (Figure 2-5A), while no peak for
that mass above background levels of detection was observed for the Δsbn Δsfa
preparation (Figure 2-5B). To further confirm that the peak at 479.110 m/z
represented SA, LC-MS/MS with collision-induced dissociation (CID) was
carried out, generating a fragmentation pattern consistent with the chemical
structure of SA (data not shown).

2.3.6 SA and SB are transported by HtsABC and SirABC, respectively and
exclusively
Given the chromosomal proximity of operon htsABC to the sfa locus, it was
hypothesized that HtsABC is responsible for transport of SA, despite an earlier
report that it contributes to staphylococcal heme acquisition (62). To
characterize the role of HtsABC in staphyloferrin transport, a ΔhtsABC mutant
allele was constructed. It has previously been demonstrated that SirABC is
involved in transport of staphylobactin/SB using a sirA insertional inactivation
mutant (18). Disc diffusion agar plate assays were used to test the interaction
between staphyloferrins and transporters, by measuring the growth promotion
caused by siderophore concentrates obtained from isogenic RN6390
staphyloferrin biosynthesis mutants toward a series of isogenic transporter
mutants seeded into an otherwise prohibitively iron chelated medium. Results
(Figure 2-6) can be summarized as follows. The ability to grow on SA was
solely dependent on HtsABC; the ability to grow on SB was solely dependent on

109

Figure 2-6. Growth on staphyloferrins A and B is dependent on ABC
transporters HtsABC and SirABC, respectively. S. aureus strain RN6390
wild type (WT) and isogenic transporter mutants were seeded in agar for a disc
diffusion assay to compare growth on concentrated culture supernatants from
donors that produce both, one, or neither of the staphyloferrins. Plates
contained TMS agar chelated with 10 µM EDDHA, suppressing growth without
addition of an exogenous iron source. Asterisks denote statistically significant
differences in diameter of growth around the disc relative to wild type treated
with the same iron amendment (P < 0.001), as calculated using the Student’s
unpaired t-test (n = 3). The dashed grey line denotes the diameter of the disc.
Error bars represent standard deviation from the mean.

Zone of growth (mm)
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SirABC; in the absence of SA and SB, S. aureus produced no detectable
growth-promoting metabolites; and, the double transporter mutant strain was
insensitive to application of a preparation replete for both staphyloferrins. It was
also observed that inactivation of hts had no effect on growth promotion by
positive controls including hemin.

2.3.7 FhuC is required for staphyloferrin transport by HtsABC and SirABC
By definition, ABC transporters harness the energy of ATP hydrolysis to
carry out translocation of a substrate across the cell membrane; however,
annotation of both htsABC and sirABC operons (Figures 1-4A and 1-5A) reveals
they are lacking candidate genes for ATP-hydrolyzing enzymes. It has been
shown that FhuC, the requisite ATPase for transport of staphylobactin (i.e. SB),
is coopted from the FhuCBG ABC transporter for hydroxamate type
siderophores of exogenous origin (63). Agar plate bioassays were used to
demonstrate that FhuC is also required for SA-dependent growth promotion in
iron-restricted medium (Figure 2-7). S. aureus strain Newman ΔfhuCBG was
unable to grow on exogenously applied S. aureus supernatant concentrates
containing SA, or on the hydroxamate siderophore ferrichrome.
Complementation with a vector encoding native FhuC protein restored growth
promotion on SA, while complementation with the entire fhuCBG operon,
including permease genes, was required to restore growth promotion on the
hydroxamate siderophore ferrichrome.
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Figure 2-7. Growth on staphyloferrins is dependent on ATPase FhuC.
S. aureus strain RN6390 wild type (WT) and its isogenic ΔfhuCBG mutant
complemented with vectors encoding fhuC (pFhuC) or the full fhu operon
(pFhuCBG) were seeded in agar for a disc diffusion assay to compare growth on
concentrated culture supernatants from donors that produce SA. Plates
contained TMS agar chelated with 10 µM EDDHA, suppressing growth without
addition of an exogenous iron source. The dashed grey line denotes the
diameter of the paper disc spotted with concentrate. Error bars represent
standard deviation from the mean (n = 3).

Zone of growth (mm)
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2.3.8 Staphyloferrins enable growth of S. aureus in serum
Several studies have demonstrated that microbial siderophores contribute
to the growth of pathogens in the iron-restricted milieu of serum (Table 1-1),
prompting the hypothesis that staphyloferrins might play a similar role for
S. aureus. To test this, S. aureus mutants inactivated for production of one or
both of SA and SB were grown in a medium comprised of 60%
complement-deactivated horse serum and 40% low-iron TMS broth (HoS-TMS).
A previous characterization of a S. aureus RN6390 sbnF mutant
(SB-deficient) described this strain as severely defective for growth in TMS due
to a lack of siderophore output (17). In this study, a strain Newman Δsbn mutant
demonstrated markedly impaired growth compared to its wild type parent within
the first 15 h of incubation, but subsequently recovered to reach an
approximately equivalent 30 h cell density (Figure 2-8A). Supplementation of
the medium with free iron obviated this defect. Despite an absence of SB,
end-point supernatant siderophore activity of the Δsbn mutant was equivalent to
that of its parent strain, as measured using the CAS assay (Figure 2-8B),
implying SA might account for this recovery. To ensure these results were not
specific to strain Newman, growth experiments were repeated using RN6390
and its isogenic staphyloferrin biosynthetic mutants, and similar growth
dynamics were observed (Figure 2-9).
In contrast to Δsbn mutants, Δsfa mutants were not noticeably impaired for
growth in horse serum (Figures 2-8A and 2-9A), despite a decrease in overall
output of siderophore into the culture supernatant (Figures 2-8B and 2-9B).
Strains lacking both sets of staphyloferrin loci, however, were severely
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Figure 2-8. Staphyloferrin production promotes growth of S. aureus
Newman in serum. (A) S. aureus strain Newman (WT) and isogenic SA and
SB deficient mutants (Δsfa, Δsbn respectively) were cultured in Hos-TMS
medium. Production of SA alone resulted in delayed growth kinetics, toward an
eventual culture density equivalent to wild type. Production of SB alone was
sufficient for wild type growth. Lack of staphyloferrin production severely
restricted growth. All mutant kinetics were ameliorated to wild type with addition
of 50 µM FeCl3 (inset). (B) Culture supernatant siderophore activity, measured
using the CAS assay, was dependent on intact sfa or sbn loci, and repressed by
addition of 50 µM FeCl3. Error bars represent standard deviation from the mean
(n = 3).
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Figure 2-9. Staphyloferrin production promotes growth of S. aureus
RN6390 in serum. (A) S. aureus strain RN6390 (WT) and isogenic SA and SB
deficient mutants (Δsfa, Δsbn respectively) were cultured in Hos-TMS medium.
Production of SA alone resulted in delayed growth kinetics, toward an eventual
culture density equivalent to wild type. Production of SB alone was sufficient for
wild type growth. Lack of staphyloferrin production severely restricted growth.
All mutant kinetics were ameliorated to wild type with addition of 50 µM FeCl3
(inset). (B) Culture supernatant siderophore activity, measured using the CAS
assay, was dependent on intact sfa or sbn loci, and repressed by addition of
50 µM FeCl3. Error bars represent standard deviation from the mean (n = 3).
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attenuated for growth (Figures 2-8A and 2-9A). This defect was presumably due
to their inability to produce siderophore above background detection levels
(Figures 2-8B and 2-9B), and growth could be corrected to wild type levels if the
medium was saturated with free iron. Taken together with data presented above
describing the inability of Δsbn Δsfa supernatant concentrates to promote the
iron-restricted growth of wild type S. aureus, these results strongly suggest that
total siderophore production is mediated by the sbn and sfa loci.
It was also of interest to determine if inactivation of staphyloferrin
transporters would result in comparable growth defects to mutating biosynthetic
loci (Figure 2-10A). Similar to the lack of a growth defect for the Δsfa mutant, a
Δhts knockout strain was not impaired for growth in horse serum relative to the
wild type parent, while a sirA insertional mutant demonstrated growth kinetics
characterized by extended lag and slower logarithmic growth, mimicking its
Δsbn counterpart. More importantly, a double sirA::Km Δhts mutant was equally
attenuated for growth to its Δsbn Δsfa counterpart. Interestingly, siderophore
output by transporter mutants did not appear compromised, as endpoint
supernatant activities of all cultures tested were roughly equivalent to the wild
type parent if normalized to cell density (Figure 2-10B).

2.3.9 Staphyloferrins enable growth of S. aureus on transferrin
Numerous microbial siderophores contribute to the extraction of iron from
the serum sequestration protein transferrin (Table 1-1), prompting the
hypothesis that staphyloferrins might play a similar role for S. aureus. To test
this, S. aureus staphyloferrin mutants were grown in TMS broth that had
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Figure 2-10. Staphyloferrin transport promotes growth of S. aureus
Newman in serum. (A) S. aureus strain Newman (WT) and isogenic SA and
SB transporter mutants (Δhts, sirA::Km respectively) were cultured in Hos-TMS
medium. Transport of SA alone resulted in delayed growth kinetics, toward an
eventual culture density equivalent to wild type. Transport of SB alone was
sufficient for wild type growth. Lack of staphyloferrin transport severely
restricted growth. All mutant kinetics were ameliorated to wild type with addition
of 50 µM FeCl3 (inset). (B) Culture supernatant siderophore activity, measured
using the CAS assay, was not dependent on intact hts or sir operons, and was
repressed by addition of 50 µM FeCl3. Error bars represent standard deviation
from the mean (n = 3).
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previously been deferrated by application of the chelating resin, Chelex-100
(C-TMS), and reconstituted for iron with 10 µM human transferrin. According to
the manufacturer’s claims, this was approximately 60% iron saturated, thus
serving as both a source of iron for strains with suitable extraction strategies, but
also as a sink of iron for strains lacking these strategies.
Despite Chelex treatment, enough contaminating iron persisted to promote
some growth of S. aureus in the absence of a deliberately applied amendment
(i.e. transferrin) (Figure 2-11). Obtaining this iron did not require staphyloferrin
production, since it was observed for the Δsbn Δsfa mutant, although either
staphyloferrin accelerated the onset of exponential growth for single locus
mutants. Holotransferrin was sufficient to promote otherwise iron-restricted
growth of S. aureus producing at least one staphyloferrin, to roughly equivalent
levels (Figure 2-11), suggesting iron extraction from this mammalian
sequestration factor is a redundant process mediated by both SA and SB. The
siderophore-deficient growth defect could be rescued with addition of sufficient
free FeCl3 to saturate transferrin (inset). In contrast to holotransferrin,
apotransferrin was detrimental to growth of all strains tested, suggesting
competition occurred for binding to free contaminating iron with staphylococcal
siderophores.

2.3.10 The sfa/hts locus is conserved in CNS
To determine whether coagulase-negative staphylococcal (CNS) sfa loci
are analogous to their S. aureus counterparts, attempts were made to correct
the S. aureus Δsbn Δsfa growth defect to a Δsbn mode of growth through
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Figure 2-11. Staphyloferrin production promotes growth of S. aureus
Newman on human transferrin. S. aureus strain Newman (WT) and isogenic
SA and SB deficient mutants (Δsfa, Δsbn respectively) were cultured in C-TMS
medium supplemented with 10 µM human transferrin (Tf), in apo- or holo(approximately 60% saturated) forms. Production of either staphyloferrin
permitted growth on holotransferrin approaching that of the wild type parent,
while lack of staphyloferrin production severely restricted growth. All mutant
kinetics on holotransferrin were ameliorated to wild type with addition of
50 µM FeCl3 (inset). Error bars represent standard deviation from the mean
(n = 3).
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expression of cloned CNS sfa loci in trans. These loci were cloned to vector
pLI50 such that expression of sfaABC and sfaD operons remained reliant on the
promoter-operator region between ORFs sfaA and sfaD (Figures 1-4A and 2-2).
For S. aureus staphyloferrin mutants grown in HoS-TMS medium,
complementation was achieved using pEV90 (sfa aureus) and pEV95 (sfa
epidermidis), but could not be achieved using pEV96 (sfa saprophyticus)
(Figure 2-12A). CAS assays performed on exponential stage culture
supernatants revealed that siderophore output was markedly high for strains
carrying pEV90 and pEV95, regardless of the iron status of the medium
(Figure 2-12B). This was likely the result of Fur protein titration due to the high
copy number of the Fur-box encoding sfa plasmids. Curiously, this was not
sufficient to compensate for SB and correct Δsbn growth kinetics to wild type.
Despite failing to contribute to the iron-restricted growth of the Δsbn Δsfa
mutant, pEV96 carriage nonetheless improved CAS activity of this strain beyond
basal levels (relative to pLI50), and subsequent studies have demonstrated that
S. saprophyticus produces a siderophore available to S. aureus in a
HtsABC-dependent fashion; the reason for a lack of growth promotion through
heterologous genetic expression of S. saprophyticus sfa genes remains
unresolved.

2.3.11 Heterologous expression of SirABC in S. epidermidis enables
growth on SB
To date, no sbn-like genetic loci have been annotated in any sequenced
CNS genomes, and with the exception of S. lugdunensis, no sir-like loci have
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Figure 2-12. sfa is conserved in S. epidermidis. (A) S. aureus strain
RN6390 growth defects in HoS-TMS arising from sfa inactivation could be
rescued in trans by sfa genes expressed from vector pLI50. Chromosomal
genotypes included wild type (WT), SB-inactivated (Δsbn), and
SA/SB-inactivated (Δsbn Δsfa). pLI50 derivatives contained sfa loci from
S. aureus (pEV90), S. epidermidis (pEV95), and S. saprophyticus (pEV96); the
latter failed to rescue the Δsfa growth defect. Presence of empty
complementation vector (pLI50) did not contribute to iron restricted growth.
Growth defects could also be rescued by addition of 50 µM FeCl3 (inset).
(B) Expression of sfa from high copy number vector pLI50 derivatives (pEV90,
pEV95, pEV96) resulted in increased siderophore production even in the
presence of 50 µM FeCl3; siderophore production was measured using the CAS
assay. Error bars represent standard deviation from the mean (n = 3).
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been annotated. S. aureus is exquisitely adapted to surviving in low iron niches;
during its evolutionary history, its genome has acquired multiple determinants
endowing transport of exogenously derived siderophores that facilitate such a
lifestyle. Certain CNS species also profit from exogenous siderophores; for
instance, S. epidermidis, whose genome encodes an annotated Fhu-like ABC
transporter, is known to use hydroxamate siderophores (19), despite not
synthesizing these molecules (49). It was thus of interest to determine if a
directed genetic acquisition event could render a CNS species capable of using
SB, which could foreshadow the emergence of more virulent strains capable of
exploiting a wider range of clinically relevant iron ligands.
This was achieved through heterologous expression of sirABC in
S. epidermidis strain 1457-M10. A biofilm deficient mutant was selected for this
experiment because of its improved transformability relative to its biofilm
proficient parental strain. Previous attempts to construct sirABC-expressing
vectors have been hindered by the apparent incompatibility of the sir-sbn
operator region in E. coli strains used for genetic manipulations, necessitating
the transcriptional fusion of this operon to an alternate staphylococcal
iron-regulated promoter. To forestall the possibility that S. epidermidis FhuC
might be unsuitable for proper functioning of SirABC, sirABC was cloned
downstream of S. aureus fhuC and its native operator region in shuttle vector
pALC2073, forming plasmid pFB54. To determine if S. epidermidis FhuC is an
adequate surrogate for its S. aureus homologue, a transcriptional fusion to a
nonfunctional Walker domain mutant allele of S. aureus fhuC was also made,
generating plasmid pFB57. Either vector rendered strain 1457-M10 responsive
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to application of a supernatant concentrate from a SB-producing, SA-deficient
S. aureus donor strain (Figure 2-13), demonstrating that genetic transfer events
between S. aureus and S. epidermidis can augment the iron uptake repertoire of
the latter’s genome.

2.3.12 Inactivating siderophore biosynthesis has a minimal impact on
virulence in a mouse sepsis model of infection
It was previously shown that S. aureus with a chromosomal inactivation of
one of the three SB synthetases was attenuated in a five to six day mouse
kidney abscess model of infection (17). In this model, S. aureus is injected to
mice intravenously but rarely persists in the blood more than a few hours; rather,
it localizes to soft tissues and seeds within organs (11). Because of their
exquisite susceptibility to bloodborne S. aureus, kidneys are the most commonly
investigated organs for quantification of bacterial load, with the hallmark of
severe infection being the formation of bacteria-laden renal abscesses. In
contrast to the previous study, numerous pilot studies with injected Newman
Δsbn and Δsfa mutants failed to demonstrate significant reductions in kidney
bacterial burden resulting from inactivation of staphyloferrin production (data not
shown); thus subsequent studies were expanded to include other organs, chiefly
livers and hearts. Spleens and lungs were also examined in some experiments,
but yielded data with extreme variability, and will not be discussed further.
Additionally, different infective loads were tested.
The results of four infection studies are presented in Figure 2-14 and
Appendix Figure A1. At a lower infective dose a significant attenuation of
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Figure 2-13. Heterologous expression of sirABC enables S. epidermidis
to grow on SB. S. epidermidis strain 1457-M10 expressing S. aureus
fhuCsirABC as a transcriptional fusion from plasmid pALC2073 (pFB54) seeded
in agar for a disc diffusion assay grew in response to addition to S. aureus
culture concentrate containing SB. A Walker domain null mutant allele of
S. aureus fhuC in the fusion (pFB57) did not compromise this growth promotion.
Plates contained RPMI agar chelated with 5 µM EDDHA, suppressing growth
without addition of an exogenous iron source. The dashed grey line denotes the
diameter of the paper disc spotted with concentrate. Error bars represent
standard deviation from the mean (n = 3).
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Figure 2-14. S. aureus Newman strains mutated in sfa and sbn loci are
minimally attenuated in a mouse systemic model of infection.
Approximately 8 x 106 CFU (A) or 5 x 106 CFU (B) S. aureus Newman and
isogenic staphyloferrin biosynthetic mutant derivatives were injected
intravenously to Charles River BALB/c immunocompetent mice. Percentage of
mouse body mass lost over four days and CFU recovered from target organs
are plotted. Statistical analysis was performed using the Student’s unpaired
t-test. P values denote significant differences from wild type (WT). Calculated
infective doses, in millions of CFU injected, were as follows: wild type, 8.000 (A)
and 6.000 (B); Δsfa, 8.625; Δsbn, 8.625; Δsfa Δsbn, 8.750 (A) and 6.000 (B).
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bacterial load in hearts was observed in Charles River mice (Figure 2-14B); this
was not reproducible using mice purchased from Jackson Laboratories
(Appendix Figure A1). No significant differences in bacterial loads between
strains were observed for other organs. These results suggest siderophore
production is not important for virulence in four-day mouse sepsis models.

2.3.13 Inactivating siderophore biosynthesis has no impact on virulence
in a mouse skin abscess model of infection
Siderophore mutants were also examined for attenuation in a mouse skin
abscess model. S. aureus Newman saline cell suspensions were injected
subcutaneously into the rear flank of Charles River nude SKH-1 or shaved
BALB/c mice (approximately 5 x 108 CFU). Pus-filled lesions appeared within
24 to 36 h, and surface area was measured at 24 h intervals for up to a week.
Lesion size generally stabilized by the second day, and data are presented for
that day (Figure 2-15). Lesion sizes were highly variable and no significant
differences were noted between wild type and isogenic siderophore biosynthetic
mutant strains.

2.3.14 Inactivating siderophore transport has a significant impact on
virulence in a mouse sepsis model of infection
The mouse sepsis infection model was approached again to assess
virulence phenotypes associated with isogenic S. aureus Newman siderophore
transport mutants. The ΔfhuCBG mutant was also tested, as a strain lacking the
FhuC ATPase is impaired for Hts and Sir-mediated transport functions. To
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Figure 2-15. S. aureus Newman strains mutated in sfa and sbn loci are
not significantly attenuated in a mouse skin lesion model of infection.
Approximately 5 x 108 CFU S. aureus Newman and isogenic staphyloferrin
biosynthetic mutant derivatives were injected subcutaneously to nude SKH-1 (A)
or shaved BALB/c (B) immunocompetent mice. An equivalent volume of sterile
saline suspension buffer was injected as a negative control. Two day lesion
areas are plotted. Statistical analysis was performed using the Student’s
unpaired T-test. Calculated infective doses, in billions of CFU injected, were as
follows: wild type (WT), 0.519 (A) and 0.319 (B); Δsfa, 0.437 (A) and 0.325 (B);
Δsbn, 0.458 (A) and 0.350 (B); Δsfa Δsbn, 0.460 (A) and 0.303 (B).
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discount any Δfhu phenotypes being attributed to loss of the FhuBG permease,
rather than the promiscuous FhuC ATPase, a fhuG transposon insertion mutant
(fhuC+) was used as a control.
In contrast to the sepsis trial involving biosynthetic mutants, strains wholly
deficient for staphyloferrin transport—i.e. the Δhts sirA::Km and the Δfhu
mutants—generated robust attenuation phenotypes in BALB/c mice. Significant
reductions (P < 0.05 using the Student’s t-test) were observed for weight loss,
kidney load, and heart load for at least one of these two mutants (Figure 2-16).
The Δfhu mutant was likely attenuated due to lack of ATPase FhuC for
HtsABC/SirABC-mediated transport processes, rather than a lack of
FhuD1/FhuD2FhuBG-mediated ferric hydroxamate transport, as the fhuGmutant performed comparably to wild type (Figure 2-16).

2.3.15 Inactivating siderophore transport enhances siderophore
production by S. aureus
Transcriptional regulation of sfa, hts, sbn, and sir is described as
iron-regulated in the paradigmatic sense, i.e. through a mechanism whereby
transcriptional derepression occurs when cellular iron levels decrease and
Fur-Fe2+ dissociates from the operator regions of genes within its regulon
(Figure 2-3 and (17, 18)). By the rules of this model it would be reasonable to
predict that a genetic mutation compromising iron uptake, including one affecting
staphyloferrin transport, would exacerbate iron starvation, consequently
enhancing expression of unchanged iron acquisition genes, including those
involved in staphyloferrin production. It has been shown that inactivation of Sir
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Figure 2-16. S. aureus Newman strains mutated in hts, sir, and fhu
operons are significantly attenuated in a mouse systemic model of
infection. Approximately 9 x 106 CFU S. aureus Newman and isogenic
siderophore transport mutant derivatives were injected intravenously to Charles
River immunocompetent mice. Percentage of mouse body mass lost over four
days and CFU recovered from target organs are plotted. Statistical analysis was
performed using the Student’s unpaired T-test. P values denote significant
differences from wild type (WT). Calculated infective doses, in millions of CFU
injected, were as follows: WT, 9.750; Δhts, 9.750; sirA::Km, 10.625; Δhts
sirA::Km, 8.875; Δfhu, 9.250; fhuG::Tn917, 8.750.
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leads to upregulation of sbn (18). In an attempt to explain why the virulence
attenuation phenotype of staphyloferrin transport mutants was much more
pronounced than that of corresponding biosynthetic mutants, the relative total
siderophore output of the host of strains used in the mouse infection models was
examined. These were grown in TMS broth and supernatant siderophore
activity was sampled at six hour intervals. In this culture medium, the only
source of iron stems from trace contamination of the other ingredients; thus it is
readily depleted by exponentially growing cells.
This medium sustained growth of all strains tested. Single-locus mutants
and the Δsfa Δsbn mutant all grew comparably to the isogenic wild type parental
strain (Figure 2-17A), and this growth was apparently not dependent on
siderophores, as the Δsfa Δsbn mutant did not render its supernatant
CAS-positive above background levels of detection (Figure 2-17B). While the
Δhts sirA::Km and Δfhu strains (i.e. strains wholly deficient for transport of
staphyloferrins) also experienced a normal lag phase and some exponential
growth, they entered stationary phase at lower culture density. Their
siderophore output, however, continued to rise drastically well into stationary
phase, well exceeding output of the parental strain. This is dissimilar to
siderophore output measured in HoS-TMS medium (Figure 2-9B), but different
results might be attributable to differences in carbon availability between
HoS-TMS and TMS. This would suggest that, at least under certain
iron-restricted growth conditions, impairing siderophore transport does not affect
siderophore production by S. aureus and may cause the organism to
hyperchelate its own surroundings.
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Figure 2-17. Inactivation of siderophore transport does not impair
siderophore production by S. aureus. (A) S. aureus strain Newman (WT)
and isogenic mutant derivatives inactivated for staphyloferrin biosynthesis (Δsfa,
Δsbn, Δsfa Δsbn) or transport (Δhts, sirA::Km, Δhts sirA::Km, Δfhu) were grown
in TMS medium. (B) Siderophore activity of culture supernatants was sampled
at 6 h intervals using the CAS assay. The mutant wholly impaired for
biosynthesis (Δsfa Δsbn) failed to generate siderophore activity above baseline
levels, while mutants wholly impaired for transport (Δhts sirA::Km and Δfhu)
demonstrated markedly enhanced siderophore output. Error bars denote
standard deviation from the mean (n = 3).
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2.3.16 S. aureus strain Newman is an efficient producer of siderophores
From the mouse infection models, it was apparent that inactivation of sbn
and sfa had minimal impact on the virulence of this strain compared to the wild
type parent, suggesting minimal reliance on siderophore-mediated iron uptake in
vivo. It was therefore of interest to compare siderophore production of Newman
to other clinically relevant S. aureus strains. These were grown in HoS-TMS
media with periodic sampling of culture supernatant siderophore activity using
the CAS assay. Growth dynamics for all wild type strains were comparable;
notably, Newman achieved higher stationary phase density than all other
isolates (Figure 2-18A). At all intervals, Newman supernatant siderophore
activity was lower than all other S. aureus strains tested, with the exception of
dermatitis-associated strain AD25 (Figure 2-18B), with the most marked
differences noted within the first 12 hours of growth. Despite apparently
secreting less siderophore than other strains, Newman output was sufficient to
counter the bacteriostatic effects of serum.

2.4 Discussion
Decades-old surveys of Staphylococcus culture collections described
members of this genus to produce at least two carboxylate siderophores: SA
and SB (34, 39, 43). More recently, Dale et al. (17) provided the first insight into
the molecular and biochemical mechanisms underlying staphylococcal
siderophore synthesis in demonstrating that the sbn operon of S. aureus
encodes NIS synthetases involved in the production of a secreted ferric iron
chelator. Lacking structural information linking the molecule to either
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Figure 2-18. Siderophore production by S. aureus strain Newman is
comparatively lower than other laboratory strains and clinical isolates.
(A) S. aureus strain Newman, its isogenic mutant derivative inactivated for
staphyloferrin biosynthesis (Δsfa Δsbn), and an array of laboratory and clinical
S. aureus isolates were grown in HoS-TMS medium. (B) Siderophore activity of
culture supernatants was sampled at 6 h intervals using the CAS assay. Strain
Newman exhibited lower amounts of siderophore production than most of the
other strains, nevertheless achieving the highest endpoint density. Error bars
denote standard deviation from the mean (n = 3).
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staphyloferrin, researchers tentatively termed the metabolite staphylobactin.
Data presented in this study (Figure 2-4) and by collaborators (12) formally
described the role of sbn-encoded enzymes in synthesis of SB. In
characterizing a synthetase mutant, Dale et al. reported that S. aureus does not
produce another siderophore and cannot grow in conditions of severe iron
eprivation. Genome sequencing projects revealed that the sbn operon is unique
to S. aureus among the staphylococci; however, a second locus encoding
putative NIS synthetases, sfaABCsfaD, is found on the chromosome of
S. aureus and among all other members of the genus. This annotation
prompted reinvestigation of the findings of Dale et al., to test the hypothesis that
the sfa locus encodes for synthetases involved in production of a second
siderophore.
The current study has revealed that under conditions of iron restriction,
SB-deficient mutants, including the strain used by Dale et al., do in fact readily
secrete siderophore (Figure 2-1). The discrepancy between studies might be
attributed to methodological differences not described in the published protocols.
Chromosomal deletion of the sfa locus abolished production of the second
siderophore, and combining this mutation with an sbn operon deletion rendered
S. aureus devoid of siderophore output. Cotton et al. (14) concurrently
demonstrated assembly of SA to be mediated in vitro by synthetases SfaD and
SfaB, and in this study sfa mutants were generated to confirm this genetic locus
is responsible for SA production (Figure 2-5). It was also shown that an
orthologous locus is responsible for production of the same metabolite for other
pathogenic staphylococci, including S. epidermidis (Figure 2-12).
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A central dogma in S. aureus physiology is that its preferred iron source
during infection is heme (62). The most abundant reservoir of iron in the
mammalian host is within heme groups of hemoglobin (23); in S. aureus, the Isd
complex of cell wall and membrane associated proteins extract and transport
heme as detailed in numerous reports (for a review, see (31)). Expression of isd
genes is directly regulated by iron and comprises part of the Fur-mediated iron
deprivation response (48). However, uncompartmentalized serum hemoglobin
(i.e. outside of erythrocytes) is relatively scarce, circulating at a concentration of
approximately 2.5 µM (53), representing 10 µM Fe. In contrast to isd genes,
expression of S. aureus haemolysins is under direct control of multiple
two-component regulatory systems, and most importantly the Agr
quorum-sensing system, such that their production occurs after the initial stages
of infection, once attachment has occurred (for a review, see (54)). Enhanced
production of lytic toxins including α- and γ-hemolysin has been documented for
a S. aureus fur- mutant (64), but mechanistic data directly linking this phenotype
to an absence of Fur repression is lacking, and this phenotype is probably a
symptom of a more global disruption of regulatory processes; in another study,
transcriptional upregulation of hemolysin genes by wild type S. aureus was not
noted for cells in vitro under conditions of iron limitation (2). Thus, haemolysin
secretion is not directly dependent on the intracellular iron status of the bacterial
cell and is likely preceded by siderophore production at the onset of invasive
infection. In comparison to hemoglobin, transferrin is found in serum at a
concentration of approximately 25 µM (4); assuming 30% saturation, this
represents a concentration of 7.5 µM Fe, rivalling the serum hemoglobin pool as
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a reservoir for iron during initial stages of staphylococcal sepsis. In fact, in
sufferers of hemochromatosis, who demonstrate above average transferrin
saturation, this protein’s reservoir may constitute a more abundant serum iron
pool than uncompartmentalized hemoglobin; hemochromatosis is well
documented as a predisposing factor to infection (38).
In this study, it was shown that the ability of S. aureus to withstand the
bacteriostatic effects of serum is alleviated through production of either
staphyloferrin (Figure 2-9), and these siderophores are required for S. aureus
proliferation on holotransferrin as a sole iron source (Figure 2-10). This is in
good agreement with the role attributed to siderophores for a range of
pathogenic bacteria (Table 1-1). However, inactivation of staphyloferrin
biosynthesis had marginal effects on S. aureus virulence in a mouse bacteremia
model of infection (Figure 2-14). With cursory consideration, this would suggest
against describing siderophores as important players in the S. aureus repertoire
of virulence factors. Other findings of this study, however, suggest further
investigation into the contributions of siderophores toward staphylococcal
pathogenesis is merited. Most importantly, it was noted that inactivation of
siderophore transport without concomitant inactivation of biosynthesis did result
in significant and reproducible attenuation of infection in the model (Figure 2-16).
This may have been a consequence of transporter mutants continuing to secrete
staphyloferrins (Figures 2-10, 2-17), to the point they enhanced the
iron-withholding capacity of their milieu. This phenomenon hints that
therapeutics incapacitating siderophore transport might be efficacious in
combating S. aureus infection. With an improved understanding of Sfa/Sbn

149
synthetase biochemistry, it might be feasible to design staphyloferrin derivatives
that compete with the natural ligands for binding to receptor proteins SirA and
HtsA, without benefiting the S. aureus cell through subsequent transport and
release of iron.
A reevaluation of the mouse as a model for studying infective processes of
a predominantly primate and livestock-adapted pathogen is merited. Mice
exhibit a remarkable innate immunity toward S. aureus infection, and the
requirement for an infective dose exceeding one million CFU, directly injected
into the bloodstream, is hardly representative of the opportunistic infective
process in humans, whereby many orders of magnitude fewer infective units
enter the bloodstream through a traumatic breach in the endothelium. To some
degree, murine innate resistance reflects the lack of coevolution between
pathogen and surrogate host; S. aureus virulence factors have evolved for
enhanced specificity toward human factors, at the expense of specificity toward
homologous factors in other genera. Pertinently, it was recently shown that
humanizing mice for hemoglobin vastly enhanced S. aureus virulence
phenotypes associated with Isd-mediated heme uptake (58). While the ability of
a siderophore to extract iron from transferrin largely reflects the higher affinity for
Fe3+ exhibited by the former, this phenomenon may also result from a more
dynamic interaction. The enteric bacterial siderophore aerobactin has an
in vitro-calculated affinity for iron well below that of transferrin (40), yet mediates
extraction of iron regardless (25), and is a noted virulence factor (67); this is
necessarily the result of an uncharacterized facet of the interaction between the
two molecules, which might further be influenced by the species from which the
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transferrin is derived. The difficulties in generating robust attenuation
phenotypes for siderophore mutants in mice may reflect decreased compatibility
of murine transferrin with staphyloferrins. It was of interest to evaluate the
growth of S. aureus on mouse transferrin, but purchasing sufficient quantities of
this molecule proved prohibitively expensive.
The adaptive significance of producing two staphyloferrins with redundant
functions is not clear, though S. aureus is certainly not unique among bacteria in
secreting multiple siderophores; this has been documented for pathogens
including Pseudomonas aeruginosa, Escherichia coli, and Bacillus anthracis, to
name a few (9, 15, 68). In certain cases, production of a second siderophore is
an adaptive mechanism countering the innate immune factor siderocalin (24).
This host protein sequesters a range of iron ligands with 2,3-catecholate iron
coordination groups, such as bacillibactin (1). To compensate for the
sequestration of this chelator during infection, B. anthracis also produces
petrobactin, which coordinates iron using one carboxylate and two
3,4-catecholate groups, and is not recognized by siderocalin; based on this
virtue, it is has been called a ―stealth‖ siderophore (71). Siderocalin evasion is
not likely to have been a selective pressure influencing the acquisition of a
second siderophore biosynthetic locus by S. aureus, as neither staphyloferrin
incorporates catechol groups; the ability of siderocalin to sequester SA and SB,
however, has not been examined. Acquisition of SB biosynthesis may
contribute to the higher virulence of S. aureus over other CNS, by giving it a
competitive advantage in the battle for iron in mixed population niches such as
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skin and mucosa; as demonstrated in Figure 2-13, SB iron is unavailable to
S. epidermidis lacking heterologously expressed SirABC.
The availability of either staphyloferrin was exclusively contingent on the
presence of its cognate transport system; no overlapping functionality between
Hts and Sir was observed (Figure 2-6). The crystal structures of HtsA bound to
Fe-SA and SirA bound to Fe-SB have been elucidated (29, 30). Both receptors
have conserved sequence and structure; both have extremely high affinities for
their ferrated ligands (Kd values in the lower nanomolar range); and for both,
ligand binding is characterized by localized conformational changes within the
binding pockets, acting to encase the siderophore, in lieu of larger, hinge-like
conformational change encompassing the greater protein structure, as occurs in
the B. subtilis tris-catecholate binding protein FeuA (57). Neither receptor has
notable affinity for the other’s ligand. Specificity is dictated in large part by
basic residues within either protein’s binding pocket positioned to cater to the
overall charge of either staphyloferrin and the geometrical distribution of
iron-coordinating atoms across either molecule’s structure. The HtsA binding
pocket is characterized by six arginine residues which act to neutralize the large
negative charge of SB (net charge of -5 when deferrated; Figure 1-4B), and are
oriented to target closely clustered Fe3+-coordinating oxygen molecules. The
SirA binding pocket is also characterized by key arginine residues; in contrast to
HtsA, these are fewer in number (three, to accommodate the -3 charge of SA;
refer to Figure 1-5B), and located on different loops of the binding pocket to
cater to the wider dispersion of Fe3+-coordinating atoms across the SB
molecule.
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This is the first study to characterize phenotypes of a siderophore-deficient
mutant of S. aureus. We have demonstrated that siderophores are major
factors contributing to the noteworthy resistance S. aureus toward the
bacteriostatic effects of transferrin. These, however, are not the only means this
pathogen has of extracting iron from transferrin; Chapter 3 is dedicated to the
characterization of an alternate mechanism, whose discovery was facilitated by
the mutant strains described in this chapter.
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Chapter 3
Catecholamine and catechol-mediated iron uptake in
Staphylococcus aureus

Significant portions of this chapter have been published in the following article:

Beasley, F. C., C. Marolda, J. Cheung, S. Buac, and D. E. Heinrichs (2011).
Staphylococcus aureus transporters Hts, Sir and Sst capture iron liberated from
human transferrin by staphyloferrin A, staphyloferrin B and catecholamine stress
hormones, respectively, and contribute to virulence. Infection and Immunity, in
press. Mouse surgeries were performed by Martha Harding, Animal Care and
Veterinary Services, University of Western Ontario.
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3.1 Introduction
Circulatory catecholamine stress hormones, including norepinephrine,
epinephrine, dopamine, and L-3,4-dihydroxyphenylalanine (L-DOPA)
(Figure 1-2), interfere with the extracellular iron scavenging functions of host
immune proteins transferrin and lactoferrin. This occurs through direct binding
of catecholamines to transferrin/lactoferrin-complexed Fe3+, with resultant
reduction to the Fe2+ valence, for which serum sequestration proteins have
minimal affinity (31). Released ferrous iron can be captured by pathogenic
bacteria (9). Alternatively, catecholamines compete with serum proteins for
coordination of Fe3+ in solution using their 3,4-dihydroxybenzoyl moieties, such
that three catecholamine molecules can complex around one iron atom in a
geometrical arrangement evocative of the enterobactin-Fe complex (see
2,3-dihydroxybenzoic acid, Figure 1-2). It was shown that a siderophore
biosynthetic mutant of E. coli was further compromised for
catecholamine-mediated capture of transferrin iron in a contact-independent
fashion (across a dialysis membrane) if the strain was also defective for
enterobactin transport (entA-), implicating the enterobactin transporter in the
additional function of capturing the Fe-catecholamine complexes (2).
Catecholamine-dependent promotion of bacterial growth has been
proposed as a contributory factor in the development of gut sepsis following
trauma with associated increases in circulating stress hormone levels (10) and
with localized destruction of norandrenergic neurons (16). Catecholamines have
also been shown to enhance growth of pathogenic bacteria on serum (1, 9, 19,
31) but empirical data linking this phenomenon to virulence is lacking. Studies
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on the stimulatory effects of catecholamines toward the growth of staphylococci
on transferrin or in serum have described a positive response by S. epidermidis
(16, 22, 31) but no response or a marginally positive response by S. aureus (22,
26, 31).
In Chapter 2, the ability of S. aureus to obtain iron from bulk serum and
from the serum iron sequestering protein transferrin was demonstrated. This
mode of growth was dependent on production of at least one of two
staphyloferrins: siderophore molecules that are assembled from amino acid and
organic acid precursors. Surveys of culture collections have thus far
demonstrated that staphylococcal isolates do not produce two other classes of
siderophore molecules, namely hydroxamates and catecholates (5, 7, 18). In
Chapter 2, the ability of S. aureus to capture xenosiderophores (siderophores
produced by other organisms) was also introduced, in the context of FhuC, the
ATPase required by ABC transporters HtsABC and SirABC for active uptake of
SA and SB, respectively. The original characterization of FhuC, however,
pertained to its role in driving the FhuDBG ABC transporter, required for growth
of S. aureus on hydroxamate-coordinating iron ligands, such as the fungal
siderophore ferrichrome (32, 35). It is also known that S. aureus uses
catecholate siderophores, such as enterobactin, for growth under iron restriction
(32), through an undescribed transport system.
Bioinformatic analysis of the S. aureus genome has uncovered operon
sstABCD (Figure 3-1), encoding a putative ABC transporter sharing sequence
identity with bacterial transport systems for various iron ligands, including
catecholate siderophores. SstD is a member of the class III substrate binding
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Figure 3-1: The S. aureus sstABCD operon. Schematic of the sstABCD
operon, encoding a predicted heterodimeric permease (SstAB), a predicted
ATPase (SstC), and a lipoprotein receptor (SstD). Numbers refer to locus tags
within the S. aureus strain Newman genome (e.g. NWMN_0702).
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protein family, a family which includes the S. aureus Fe3+-staphyloferrin
receptors HtsA and SirA, and shares significant sequence identity (E = 9e-59)
with the Bacillus subtilis petrobactin receptor YclQ (39). The sst operon is
transcriptionally upregulated under conditions of iron deprivation (21),
suggesting a role in the adaptive response to restrictive environments such as
serum; the same study, however, did not identify any ligands for receptor
lipoprotein SstD, and genomic inactivation of the transporter did not compromise
virulence in a rat chamber implant model of infection. In this study, it was shown
that S. aureus is in fact capable of catecholamine-mediated acquisition of serum
iron, but this phenomenon is secondary to staphyloferrin-mediated iron uptake
in vitro and can only be observed in the absence of siderophore production
using sfa/sbn mutants. Mutants lacking Sst were unable to grow on
xenosiderophores using catechol iron coordinating groups exclusively, including
enterobactin, suggesting Sst is a broad specificity transporter of catecholate
iron-coordination ligands. Inactivation of sstABCD enhanced the attenuation
phenotype of siderophore biosynthesis and transporter mutants in the mouse
sytemic model of infection, suggesting the ability of S. aureus to acquire iron
from host serum is the sum of multiple mechanisms and not exclusively limited
to staphyloferrin-mediated uptake.

3.2 Materials and methods
3.2.1 Bacterial growth conditions
Bacterial strains include those summarized in Table 2-1 and additional
strains summarized in Table 3-1. Growth conditions, including temperature,
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composition of media, and selective concentrations of antibiotics used were as
described in Section 2.2.1. An additional growth medium used consisted of
80% C-TMS with 20% human serum (HuS-TMS). Human serum was collected
from healthy volunteers without use of heparin sulfate; serum was separated
from blood cells immediately upon collection by centrifugation at 2000 X g for
20 min at 4 oC, and complement was deactivated through incubation at 55 oC for
2 h.

3.2.2 General molecular genetic methodologies
DNA purification, manipulation, and recombination was performed
essentially as described in Sections 2.2.2 and 2.2.3, with additions/modifications
described below.

3.2.3 Mutagenesis of S. aureus
Oligonucleotides and plasmids strains used in this study are summarized
in Tables 2-1 and 3-1. Allelic replacement was used to delete the majority of
operon sstABCD from the chromosome of S. aureus. The operon and flanking
regions were PCR amplified from strain RN6390 and cloned into plasmid
pBAD24 using restriction enzymes SalI and XbaI. The majority of the operon
was excised via PvuII digestion. A Klenow-blunted BamHI restriction fragment
containing an erythromycin resistance cassette was prepared from plasmid
pDG646 and cloned into the PvuII restriction site. The ΔsstABCD::Em knockout
allele was excised using restriction enzymes SalI and XbaI, and cloned to vector
pAUL-A-Km, generating pSB10. Subsequent passage through S. aureus
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Table 3-1: Bacterial strains, plasmids, and oligonucleotides used in this
study
Description

Ref.

H1861

RN6390 ΔsstABCD::Em

This study

H2221

Newman ΔsstABCD::Em

This study

H2224

Newman sirA::Km ΔhtsABC::Tc
ΔsstABCD::Em

This study

H2228

Newman ΔsbnABCDEFGHI::Tc
ΔsfaABCsfaD::Km ΔsstABCD::Em

This study

Bacillibactin-producing strain

(27)

BL21ʎ(DE3)

F- ompT hsdSB(rB-, mB-) dcm gal ʎ(DE3)

Novagen

AN102

Enterobactin-producing strain

(6)

pBAD24

E. coli cloning vector; ApR

(15)

pDG646

E. coli vector containing the ermC gene; ApR (14)

pGEX-2T-TEV

E. coli vector for overexpression of
(33)
recombinant proteins with tobacco etch virus
protease cleavable glutathione-Stransferase (GST) tags; ApR

pJB1

pGEX-2T-TEV derivative for overexpression
of SstD with a TEV-cleavable GST; ApR

This study

pSB5

pLI50 derivative carrying sstABCD; CmR

This study

pSB10

pAUL-A derviative carrying ΔsstABCD::Em
allele; EmR

(3)

S. aureus strains

Bacillus subtilis
strains
HB5800
Escherichia coli
strains

Plasmids
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Table 3-1 continued
Oligonucleotides*
sst5’-SalI
sst3’-XbaI-1
sst3’-XbaI-2

sstD-28/343-5’BamHI
sstD-28/343-3’

5’ AAAAGTCGACGGAATCACTGAAGATGTG 3’
5’ GGGGTCTAGAGGTGAACATCCAAAGGAATCGTA 3’
Generation of ΔsstABCD::Em allele
5’ CCCCTCTAGACAATGATTAAGACCTTTAACCAT 3’
Cloning of sstABCD to pLI50 for complementation (with
sst5’-SalI)
5’ TTGGATCCCAATCAAAATCAGAAACTAAAGG 3’
5’ CCTTTAACCATTGTTCCCCTCTTT 3’
Cloning of soluble portion of sstD (codons 28-343) to
pGEX-2T-TEV for overexpression

* underlined sequences in oligonucleotides denote restriction sites
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strains, recombination into the chromosome with colour-based selection, and
transduction between strains was performed as described in Section 2.2.3.

3.2.4 Complementation of the Δsst mutation
The chromosomal ΔsstABCD::Km mutation was complemented in trans
using plasmid pSB5, which was generated by cloning PCR-amplified,
SalI/XbaI-digested sstABCD into plasmid pLI50.

3.2.5 Bacterial growth curves and plate bioassays
For generation of growth curves, S. aureus cells grown to stationary phase
in TMS with 100 µM 2,2-dipyridyl were washed twice in saline buffer and diluted
1:100 into HuS-TMS or C-TMS containing 10 µM human transferrin. Culture
medium was left iron depleted or enriched with 100 µM FeCl3 (iron replete).
Other culture medium amendments included 50 to 200 µM catecholamine
hormones (norepinephrine, epinephrine, dopamine, or L-DOPA)
(Sigma-Aldrich). Norepinephrine and dopamine were purchased as
hydrochlorides and dissolved in water to generate stock solutions; dopamine
and L-DOPA were dissolved in equimolar and twice equimolar concentrations of
HCl, respectively.
Disc diffusion plate availability bioassays were performed as described in
Section 2.2.11. Discs were spotted with 20 µL of 750 µM stocks of
catecholamines (described above) or 2,3-dihydroxybenzoic acid
(Sigma-Aldrich), or 250 µM stocks of the following catecholate siderophores:
enterobactin-Fe, petrobactin-Fe, salmochelin S-4-Fe (EMC Microcollections
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GmbH), or bacillibactin (described below). All ligands were ferrated with 50 µM
FeCl3 if not described as ferrated by the vendor.
Bacillibactin was purified from B. subtilis strain HB5800 as described (11),
with modifications. Briefly, B. subtilis was grown in enterobacterial minimal
culture medium (23) with modifications as described (4) for 48 h. Cells were
removed by centrifugation and culture supernatant was acidified to pH 3 with
HCl then extracted three times with 200 mL volumes of ethyl acetate. Pooled
ethyl acetate fractions were dried over NaSO4, filtered, and dried in a rotary
evaporator. Residue was dissolved in 1 mL methanol and added dropwise into
50 mL stirred ether. Precipitate was pelleted by centrifugation, air dried, and
resuspended in dimethyl sulfoxide. Bacillibactin concentration was calculated by
measuring absorbance at 318 nm as described (24).

3.2.6 Generation of anti-SstD antiserum
The soluble portion of the sstD gene (downstream of the lipoprotein
consensus sequence) was PCR-amplified and cloned into plasmid
pGEX-2T-TEV using restriction sites BamHI and SmaI, generating plasmid pJB1
in E. coli strain BL21λ(DE3). For overexpression of SstD-GST, E. coli cells were
grown at 30 °C to mid log phase, induced with 0.4 mM isopropyl
β-D-1-thiogalactopyranoside, and grown for another 16 h. Cells were collected
by centrifugation and ruptured using a French press. Insolubles and cellular
debris were removed following centrifugation at 5000 x g for 15 min then at
164000 x g for 60 min. Filtered supernatant was passaged over a 5 mL GSTrap
FF column (GE Healthcare) and eluted in buffer containing 50 mM Tris and
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10 mM reduced glutathione, pH 8.0. SstD-GST was digested with recombinant
hexahistidine tagged TEV protease (home brewed) overnight at 4 °C. GST and
uncleaved SstD-GST were removed with a second passage over the GSTrap FF
column and TEV protease was removed by passaging over a 1 mL HisTrap
column (GE Healthcare). SstD concentration was calculated using a Bio-Rad
protein assay as instructed (Bio-Rad).
Polyclonal antibodies against soluble SstD were generated in New Zealand
white rabbits by ProSci Inc. using custom antibody production protocol 1.

3.2.7 Immunoblot analysis of whole cell lysates
S. aureus strains precultured as described in Section 3.2.5 were grown in
HuS-TMS to mid-log phase. Cells from approximately 1.5 mL of culture were
pelleted by centrifugation and incubated for 30 min at 37 oC in 100 µL cell wall
digestion buffer containing 0.3 g/L raffinose, 50 µM Tris-Cl (pH 7.5), 145 mM
NaCl, 5 mM iodoacetamide, 0.1 mM phenylmethanesulfonylfluoride, and 1 µg
lysostaphin (Sigma-Aldrich). Sample total protein concentrations were
calculated using the Bio-Rad protein assay following the manufacturer’s
instructions (Bio-Rad). Samples were boiled for 10 min, and sample volumes
normalized to contain 10 µg total protein were resolved through
SDS-polyacrylamide gel electrophoresis (12% acrylamide resolving gel) then
transferred to 45 µm nitrocellulose membrane, according to standard protocols
(30). Detection of SstD on nitrocellulose was performed after the following
steps: 12 h of blocking at 4 oC in phosphate-buffered saline (PBS) containing
20% horse serum (Sigma-Aldrich) and 10% w/v skim milk; 2 h exposure to the
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primary antibody at room temperature in PBS containing 0.05% Tween-20 and
2% w/v skim milk (1:7500 dilution of rabbit antiserum); 1 h exposure to
secondary α-rabbit IgG antibody conjugated to IRDye-800 (LI-COR Biosciences)
at room temperature in PBS/0.05% Tween/2% skim milk (1:10000 dilution of
antibody). Immunoblot fluorescence was imaged using a LI-COR Odyssey
Infrared Imager (LI-COR Biosciences).

3.2.8 SstD ligand binding assays
SstD was adjusted to 1 µM in 100 mM NaCl, 10 mM Tris pH 8.0.
Equimolar bovine serum albumin (Sigma Aldrich) was used as a protein
negative control. Ligand stocks were added in twofold concentration increments
ranging between 0 and 40 µM. Ligands included enterobactin, salmochelin,
petrobactin, bacillibactin, 2,3-DHBA, norepinephrine, epinephrine, dopamine,
L-DOPA and DesferalTM. For ferration, ligands were incubated for 5 min at room
temperature with FeCl3 at a ratio of 1:3 (Fe:catecholamines) or 1:1
(Fe:siderophores). Ligand affinity was measured at room temperature using
intrinsic tryptophan fluorescence quenching in a Cary Eclipse (Agilent
Technologies). Excitation was performed at 280 nm and fluorescence was
detected at 345 nm using a excitation slit width of 5 nm and emission slit width
of 5 nm. For ferrated catechol siderophores, fluorescence data were corrected
for nonspecific tryptophan quenching by ligands after analogous titration with
1 µM N-acetyl-tryptophanamide, as described (37). The volume of starting
protein solutions were 500 L and data were corrected for changes in
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fluorescence due to changes in sample volume due to ligand additions.
Fluorescence data were fitted to nonlinear regression analysis using a one-site
binding model and data were analyzed using Microsoft Excel.

3.2.9 Mouse models of S. aureus infection
Mouse infection experiments were performed using Charles River or
Jackson Laboratories BALB/c mice as described in Section 2.2.12. Additionally,
an infection study was performed on mice carrying surgically implanted
norepinephrine dispensers to evaluate the contribution that elevated circulatory
catecholamine levels make on the progression of staphylococcal disease. 48 h
prior to infection, mice purchased from Charles River were anaesthetized with
isofluorane gas and administered with 1 mg/kg of the analgesic meloxicam
(Boehringer Ingelheim) in 400 µL saline solution via intraperitoneal injection.
The right flank of each mouse was shaved and disinfected with a routine three
step scrub. A dorsoventral incision was made near the shoulder and a region of
skin orienting toward the hips was undermined. Alzet 2001 osmotic pumps
(Durect Corp., dispensing rate of 1 µL/h) loaded with 1 mg/mL epinephrine in
0.8% buffered saline, pH 4 (Bioniche Life Sciences, Inc.), were inserted into the
fold. Drug dosage and osmotic pump model were selected based on a previous
report (36). pH-adjusted sterile saline-loaded pumps were inserted for mice in a
drug-free control group. Incisions were closed with sutures. 24 h prior to
infection, mice were administered a second dose of meloxicam. Mice were
monitored daily for symptoms of adverse reactions to the surgical procedure,
prior to and during the staphylococcal infection trial; none were noted.
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3.3 Results
3.3.1 Catecholamine stress hormones promote the growth of S. aureus in
serum and on transferrin in the absence of siderophore production
Catecholamines stimulate the growth of S. epidermidis on transferrin (17,
22), although a similar effect was not noted for S. aureus (22, 26, 31). In this
investigation, four catecholamine hormones, including norepinephrine,
epinephrine, dopamine, and L-DOPA, did not enhance growth of wild type
S. aureus on human serum or human holotransferrin when added at a
concentration of 50 µM. They did, however, partially restore the growth of the
siderophore-deficient strain at the same concentration (Figures 3-2A, 3-3).
Serum growth promotion up to levels conferred by siderophore production could
be achieved at catecholamine concentrations of 200 µM (Figure 3-2B).
Catecholamine-stimulated growth promotion in basal culture medium was
negligible in the absence of holo-transferrin or whole serum, ruling out the
possibility that the commercially obtained molecules were preloaded with iron
(data not shown).

3.3.2 Uptake of catecholamine-liberated serum iron occurs through
transporter SstABCD
The proposed model for the 3:1 molar complexation of a catecholamine
hormone with Fe3+ in solution resembles the mechanism by which the three
coordinating moieties of bacterial catechol siderophores orient around a central
Fe3+ atom (31). Following the observation that catecholamine hormones
stimulate growth in serum in the absence of siderophores, it was of interest to
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Figure 3-2: Catecholamine stress hormones enhance the growth of
siderophore-deficient S. aureus on human serum. Wild type S. aureus strain
Newman (WT) and its siderophore nonproducing isogenic mutant (Δsbn Δsfa)
were grown in HuS-TMS. Catecholamine stress hormones
(NE = norepinephrine; E = epinephrine; D = dopamine; LD = L-DOPA) were
added to concentrations of 50 (A) or 200 µM (B). FeCl3 (Fe) was added to a
concentration of 100 µM. Hormones only marginally improved the growth of the
wild type strain (NE used as a representative curve). Error bars represent
standard deviation from the mean (n = 3).
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Figure 3-3: Catecholamine stress hormones enhance the growth of
siderophore-deficient S. aureus on human transferrin. Wild type S. aureus
strain Newman (WT) and its siderophore nonproducing isogenic mutant (Δsbn
Δsfa) were grown in C-TMS with 10 µM human holo-transferrin (~60%
iron-saturated). Catecholamine stress hormones (NE = norepinephrine;
E = epinephrine; D = dopamine; LD = L-DOPA) were added to concentrations of
50 µM. FeCl3 (Fe) was added to a concentration of 100 µM. Hormones only
marginally improved the growth of the wild type strain (NE used as a
representative curve). Error bars represent standard deviation from the mean
(n = 3).
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determine what transport system might be involved in catecholamine iron
uptake. Based on the shared sequence identity between the components of
SstABCD and other bacterial iron transporters, and a report describing its genes
to be iron regulated (21), the sst operon was chosen for chromosomal deletion
through allelic replacement. With production of staphyloferrins, a ΔsstABCD
mutation did not have adverse effects on growth in human serum compared to
an isogenic wild type parental strain (Figure 3-4A). The mutation, however,
rendered a siderophore deficient mutant insensitive to the growth promoting
effects of catecholamines, at concentrations as high as 200 µM. Similar defects
were observed on human transferrin as a sole iron source (data not shown).
The mutant phenotype was fully complemented by expression of wild type
sstABCD in trans (Figure 3-4B).

3.3.3 SstD is expressed by laboratory and clinical strains of S. aureus
Western blots against whole cell lysates using polyclonal SstD antiserum
confirmed a lack of detectable SstD expression in the Newman ΔsstABCD
mutant strain (Figure 3-5A). Conserved expression of SstD through a range of
commonly used laboratory and clinical strains, including three communityacquired strains, was also noted (Figure 3-5C).

3.3.4 SstD binds a range of catechol-coordinating Fe3+ ligands
Fluorescence quenching assays were used to measure the affinity of
purified SstD for catecholamines and catechol siderophores. Titration with
iron-free hormone or siderophore ligands showed no quenching of the
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Figure 3-4: SstABCD is required for catecholamine-mediated growth on
serum. (A) Catecholamine stress hormone-mediated growth promotion of a
siderophore nonproducing mutant of S. aureus strain Newman (Δsbn Δsfa) was
negated by concomitant mutagenesis of sstABCD (Δsbn Δsfa Δsst). Strains
were grown in HuS-TMS. Catecholamine stress hormones
(NE = norepinephrine; E = epinephrine; D = dopamine; LD = L-DOPA) were
added to concentrations of 200 µM. FeCl3 (Fe) was added to a concentration of
100 µM. (B) Expression of sstABCD from vector pSB5 restored growth with
200 µM norepinephrine in HuS-TMS. Error bars represent standard deviation
from the mean (n = 3).
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Figure 3-5: Detection of SstD in S. aureus whole cell lysates using
polyclonal antiserum. (A) Polyclonal anti-SstD rabbit antibodies were used to
confirm mutagenesis of the sst operon in S. aureus strain Newman in a Western
blot. 1 = 1 µg purified SstD (soluble portion); 2 = wild type Newman;
3 = Newman Δsst mutant; 4 = SDS-PAGE low molecular weight ladder. (B),
(C) A selection of S. aureus strains’ whole cell lysates normalized to total
protein content, confirmed with a Coommassie stain of a SDS-PAGE gel (B),
were probed with anti-SstD serum in a Western blot (C). 1, 9 = SDS-PAGE low
molecular weight ladder; 2 = RN6390; 3 = Newman; 4 = USA300 LAC;
5 = MW2; 6 = MSSA476; 7 = UAMS-1; 8 = AD25. The yellow arrows denote
which band corresponds to SstD.
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tryptophan/tyrosine fluorescence of SstD (data not shown). The fluorescence of
bovine serum albumin, a protein negative control, was not quenched with any of
the ligands tested (data not shown). SstD fluorescence was quenched by all
four ferrated catecholamines tested ferrated catechol siderophores.
Dissociation constants are reported in Table 3-2.

3.3.5 SstABCD contributes to virulence
A mouse systemic model of infection was used to evaluate the relative and
combined contributions of siderophore biosynthesis, siderophore transport, and
catecholamine iron acquisition genes in vivo. Mice were infected intravenously
with approximately 5 to 10 x 106 bacteria and bacterial loads in target organs
were enumerated 96 h postinjection. Trials were performed using both Charles
River and Jackson Laboratories mice. Bacterial processes disrupted via
mutation included catecholamine iron uptake (sst), siderophore biosynthesis
(sbn sfa), and siderophore uptake (sirA hts). Furthermore, the effect of
combined mutations for catechol iron uptake with staphyloferrin biosynthesis
(sbn sfa sst) or staphyloferrin uptake (sirA hts sst) were tested. Disruption of
any single process resulted in a mild but significant reduction in heart
colonization in Charles River mice, and combined inactivation of all three
transport systems resulted in attenuation phenotypes in kidneys, livers, and
hearts for both Charles River and Jackson Laboratories mice (Figure 3-6,
Appendix Figure A2).
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Table 3-2: Dissociation constants (Kd) for SstD-ferric-catecholamine and
SstD-ferric-catechol complexes
Ligand
Norepinephrine
Epinephrine
Dopamine
L-DOPA
Bacillibactin
2,3-DHBA

Enterobactin
Petrobactin
Salmochelin S-4

Kd (µM)

Standard
deviation

1.07
1.65
0.49
1.44
1.21
1.62
0.29
1.62
0.35

0.54
0.08
0.22
0.27
0.14
0.27
0.06
0.25
0.20
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Figure 3-6: Inactivation of siderophore and catecholamine transport
attenuates S. aureus Newman in a mouse systemic model of infection.
Approximately 5 to 10 x 106 CFU S. aureus Newman and isogenic iron transport
mutant derivatives were injected intravenously to Charles River BALB/c
immunocompetent mice. Percentage of mouse body mass lost over four days
and CFU recovered from target organs are plotted. Statistical analysis was
performed using the Student’s unpaired t-test. P values denote significant
differences from wild type (WT) (*) or from an isogenic siderophore
biosynthesis/transport mutant parent (**). Infective doses were as follows (in
millions of CFU/dose): 7.00 (WT), 5.50 (Δsbn Δsfa), 5.75 (sirA::Km Δhts), 5.00
(Δsst), 6.00 (Δsbn Δsfa Δsst), 6.50 (sirA::Km Δhts Δsst).
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3.3.6 Augmentation of circulating epinephrine levels does not render
mice more susceptible to S. aureus infection
Mice implanted with steady dose epinephrine dispensers were evaluated
for enhanced susceptibility to S. aureus infection. In a pilot trial, it was observed
that mice receiving surgical implants exhibited reduced external symptoms of
infection compared to a surgery-free control group (less pronounced weight loss,
fewer signs of septic arthritis, and generally healthy grooming and activity
patterns), despite mice having been administered a typically infective dose of
bacteria (~5.0 x 106 CFU). Post mortem analysis described atypically low
bacterial colonization in target organs for implant-carrying mice (data not
shown). It was thus hypothesized that the surgical procedure elicited an
immunostimulatory change in mice prior to infection, so subsequent experiments
were performed using a higher infective dose (~1.0 x 107 CFU).
In the first experiment, mice carrying epinephrine-dispensing pumps proved no
more susceptible to infection with wild type S. aureus strain Newman than mice
implanted with saline pumps (Figure 3-7). Both surgical groups exhibited
decreased amounts of organ colonization than surgery-free control mice,
although data did not achieve statistical significance; surgery-free mice,
however, did experience significantly more weight loss, in agreement with the
pilot study.
In the second experiment, mice carrying epinephrine-dispensing pumps
proved no more susceptible to infection with wild type S. aureus Newman than
its isogenic Δsst mutant derivative (Figure 3-8). In agreement with data
presented in Chapter 2, mice experienced reduced rates of colonization in the
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Figure 3-7: Subcutaneous epinephrine pumps alter mouse immunity but
epinephrine does not enhance virulence of S. aureus. Charles River BALB/c
immunocompetent mice were fitted with subcutaneously implanted osmotic
pumps dispensing 1 µL/h 1 mg/mL epinephrine (epi) or buffered saline (saline),
or were not surgically treated (none). Weight loss and organ bacterial loads
were calculated four days postinfection with S. aureus Newman (intravenous
infective dose of 4 x 106 CFU). Statistical analysis was performed using the
Student’s unpaired t-test. P values denote significant differences from
epinephrine (*) or from saline treatment (**).
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Figure 3-8: Subcutaneous epinephrine pumps do not enhance virulence of
S. aureus expressing SstABCD. Mice were fitted with subcutaneously
implanted osmotic pumps dispensing 1 µL/h 1 mg/mL epinephrine (epi). Weight
loss and organ bacterial loads were calculated four days postinfection with
S. aureus Newman. Intravenous infective doses were as follows (in millions of
CFU/dose): 8.00 (WT), 8.50 (sirA::Km Δhts), 9.00 (Δsst), 9.75 (sirA::Km Δhts
Δsst). Statistical analysis was performed using the Student’s unpaired t-test.
P values denote significant differences from wild type.
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heart with S. aureus sir/hts mutants; this was not, however, enhanced by
simultaneous inactivation of sst.

3.3.7 SstABCD contributes to growth on catecholate siderophores
It was previously reported that S. aureus strain RN6390 is capable of
growing on ferric enterobactin, a tris-catecholate enteric siderophore, in a plate
bioassay (32). Having established that SstABCD plays a role in uptake of
catecholamine-liberated serum iron, it was of interest to investigate a possible
role for the transporter in uptake of exogenous catechol siderophores.
Curiously, when strain Newman and its isogenic Δsst mutant derivative were
examined for growth promotion on enterobactin, other catechol-coordinating
siderophores, and catecholamines, following prescribed protocols (32), no
enterobactin growth promotion was observed even for the wild type parent. The
study was expanded to include RN6390, its Δsst mutant, and the host of clinical
isolates first mentioned in Chapter 2 (Tables 2-1, 3-1). Data are presented in
Figure 3-9. Strains AD25 and UAMS-1 were discounted from the study as no
amount of EDDHA chelation tested (up to 30 µM) was sufficient to eliminate
substrate-independent background growth, making growth promotion around a
disc unquantifiable; the mechanism for this phenomenon is unclear. Unlike for
strain Newman, all isolates tested formed growth halos around three of the four
catecholamines (L-DOPA excluded), and catecholate siderophores enterobactin,
salmochelin S-4, bacillibactin, and petrobactin; Newman was responsive only to
petrobactin, and as evidenced by the RN6390 Δsst mutant, this siderophore is
not exclusively reliant on SstABCD for transport. Strain Newman was
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Figure 3-9: Plate bioassay growth promotion using ferrated
catecholamines and catechol siderophores. A host of S. aureus strains
seeded in TMS agar chelated with 10 µM EDDHA were evaluated for growth
halo formation around a paper disc spotted with 20 µL ferrated catecholamine
hormones (750 µM), 2,3-dihydroxybenzoic acid (750 µM), catechol siderophores
(250 µM), or FeCl3 (50 µM). Growth was measured after incubation at 37 oC for
36 h. Growth is represented as the diameter of the halo (in mm). The dashed
line represents the diameter of the paper disc. Error bars represent standard
deviation from the mean (n = 3).
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subsequently demonstrated to be weakly responsive to enterobactin at
millimolar concentrations (data not shown). FeCl3 added at equimolar
concentration was only weakly growth promoting, at best, for any strain
examined.

3.4 Discussion
A key theme of the S. aureus iron uptake strategy is the blending of
redundancy and complexity in targeting specific iron reservoirs. In the preceding
chapter, the ability of S. aureus to capture iron from transferrin and bulk serum
through two redundant siderophores, was demonstrated. Here, the molecular
basis of an alternate mechanism for holotransferrin iron extraction has been
elucidated. This second mechanism capitalizes on the liberation of
holotransferrin iron following complexation with mammalian catecholamine
stress hormones (31). Catecholamine iron was shown to promote the growth of
Bacillus and E. coli on holotransferrin at concentrations comparable to those
tested in this study (2, 20). Similar to this study, the role was characterized in
strains mutated to inactivate production of the catecholate siderophores
bacillibactin (Bacillus) and enterobactin (E. coli). Uptake was dependent on
either organism’s catechol siderophore ABC transporter. Due to the
overshadowing contribution of staphyloferrins, characterizing the contribution of
catecholamines toward iron uptake from human serum or transferrin was made
possible only after constructing and characterizing two whole-locus siderophore
biosynthesis knockout strains (Figures 3-1, 3-3). Catecholamine iron uptake
was subsequently shown to be mediated by a distinct transporter, SstABCD
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(Figures 3-2, 3-4), previously implicated in the S. aureus adaptive response to
low iron environments (21).
A large reservoir of plasma catecholamines is found in the venous and
arterial circuitry between mesenteric organs, kidneys, and the liver (8). While
hormone concentrations tested in this study (50 to 200 µM) have been alluded
to as physiologically or therapeutically relevant (10, 20), typical serum reference
ranges are in the nanomolar range (28), and it is unlikely they approach
micromolar concentrations in bulk plasma even after gastric surgery. In fact, a
catecholamine concentration of 100 µM has been reported as neurotoxic in vitro
(25). Nevertheless, in concert with siderophore activity, low concentrations of
stress hormones may subvert the bacteriostatic effects of transferrin to promote
sufficient proliferation in the bloodstream for evasion of phagocytic immune cells
prior to colonization of organs. This highlights the necessity for precaution prior
to therapeutic administration of catecholamines. Catecholamines might also be
found in elevated levels in microenvironments surrounding wounds where
nervous damage has occurred. Other research has noted increases in
indigenous bacterial gut flora following localized destruction of noradrenergic
neurons (16). In addition to providing a source of iron, these wounds provide an
epithelial breach through which opportunistic bacteria may enter the
bloodstream.
Previously, SstABCD was shown to make no significant contribution to
bacterial survival in a rat intraperitoneal cage model of infection (21). In this
study, sst inactivation significantly decreased colonization of the mouse heart or
liver in two separate trials (Figure 3-6 A and B, respectively). This finding is
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significant as S. aureus is a leading cause of infective endocarditis. Additionally,
a mutant lacking both siderophore transport systems was consistently further
attenuated in mouse kidneys, livers, and hearts by inactivation of sst
(Figures 3-6A and B), demonstrating that highly coordinated extraction of iron
from host sources other than hemoproteins contributes to the pathogenesis of
S. aureus.
Elevation of a circulating catecholamine stress hormone, specifically
epinephrine, did not render mice more susceptible to S. aureus infection
(Figure 3-7), nor did it result in a difference in bacterial loads in mouse organs
between wild type Newman and its isogenic sst mutant (Figure 3-8). These
experiments proved to be extremely technically challenging and negative results
could reflect inadequate protocol rather than a genuine lack of
catecholamine-enhanced virulence. Owing to the extremely short half life of
stress hormones in circulation (minutes) (34, 38), the only way to ensure steady
dispensing of epinephrine within a mouse for the duration of the experiment (two
days pre- and four days post-infection) was to use an implanted pump roughly
equal in weight to 10% of the mouse’s body mass. This invasive and intensive
surgical procedure clearly affected the innate immunity of the mouse toward
S. aureus by mechanisms unknown. While such a stress would intuitively
render mice more susceptible to further medical insult, i.e. infection, the opposite
was in fact observed; surgery enhanced the innate resistance of mice to
S. aureus challenge, reflected in improved symptoms assessed externally and
internally (Figures 3-6, 3-7). Future experiments to correlate increased levels of
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circulating catecholamines to enhanced infectivity of S. aureus should involve
larger animals with a more manageable body to implant mass ratio.
The opportunistic coopting of other organisms’ siderophores may provide
S. aureus with a competitive advantage in heterogeneously colonized host
niches such as on skin or in the nares. Little is known about the dissemination
of enteric catechol siderophores from the gut flora and it is possible that these
may be found in sufficient quantities to contribute to growth of invasive
S. aureus, confirmed here to be capable of growth on exogenous
catecholate-type siderophores (Figure 3-9). Strangely, in bioassay conditions,
there appear to be strain-specific differences in the ability to grow on these
siderophores which did not correlate to strain-to-strain expression of SstD on the
surface of iron-starved S. aureus cells (Figure 3-5 C). This may reflect inherent
differences in cellular metabolic requirements between strains rather than an
inability to transport iron ligands. Strain Newman was not responsive to ferrated
catecholamines or catecholate siderophores, while the other strains tested in the
plate bioassay exhibited varying degrees of growth around the supplied iron
ligands. (It was subsequently determined that Newman would begin to grow on
enterobactin spotted from a stock solution of 500 µM, while the data presented
in Figure 3-9 represent growth on 250 µM.) Another interesting finding was that
in the absence of SstABCD, siderophores salmochelin S-4 (glucosylated
tris-catecholate) and petrobactin (bis-catecholate + carboxylate) promoted the
growth of strain RN6390, albeit to a lesser degree than for the wild type parent.
This could explain why strain Newman did form a growth halo around
petrobactin; uptake efficiency was enhanced by redundancy in transport
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systems. Salmochelin S-4 clearly enters S. aureus RN6390 through an
alternate transporter to SstABCD as well.
SstD demonstrated affinity for ferrated catecholamines and catecholate
siderophores; for all ligands, Kd values were in the M range (Table 3-2). The
Kd values resemble those determined for the B. subtilis FeuA protein and
ferric-norepinephrine complex (1.6 M) (20). Interestingly, of all ligands
examined, SstD had the highest affinity for the enteric siderophores enterobactin
and salmochelin S-4, suggesting that under certain favourable conditions, these
ligands might be viable iron sources for S. aureus in vivo, in spite of the
inconsistent ability of these siderophores to stimulate growth of S. aureus strains
in vitro. The Kd values of SstD for its ligands, in the M range, contrasts with the
Kd values in the nM range that were determined for HtsA and SirA for their
cognate ligands, staphyloferrin A and staphyloferrin B (12, 13). In line with the
M range of affinities of E. coli FhuD for several hydroxamate ligands (29), this
might reflect a sacrifice in ligand affinity in lieu of greater ligand diversity.
Findings presented here demonstrate that inactivation of three
transporters, namely Sir, Hts, and Sst, inhibits utilization of transferrin-iron.
Combined with the lack of inhibitory feedback on siderophore production, this
strain may enhance the bacteriostatic potential of its milieu through the secretion
of nonviable iron chelators. This phenomenon may underlie the reduced fitness
of the Δsst Δhts sir- transporter mutant relative to the Δsst Δsfa Δsbn mutant in
the murine infection model used in this study. In combination, these lipoproteins
may be worthy candidates for inclusion in a multivalent antistaphylococcal
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vaccine, wherein the effectiveness of antibodies would rely upon inhibiting
transporter function.
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Chapter 4
General Discussion
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4.1 General overview
In this report, we have described two mechanisms through which S. aureus
extracts iron from serum using endogenously derived molecules. These
comprise the essentially redundant strategies of secreting a high affinity Fe3+
chelator, i.e. siderophore, produced by enzymes encoded from the sfa or sbn
loci. Using mutants inactivated at those loci, the siderophores were shown to be
staphyloferrins A and B (SA and SB), in agreement with previous studies that
interrogated staphylococcal culture collections for siderophore production (20,
28, 32), and with concomitant biochemical studies characterizing the functions of
S. aureus synthetases (9, 11). Furthermore, it was shown that SB is the same
metabolite as the previously reported staphylobactin molecule (12). The
staphyloferrins extract ferric iron from transferrin and facilitate its active uptake
by the S. aureus cell through ABC transporters HtsABC and SirABC. Production
of either of these siderophores was sufficient for maximal growth in human and
animal sera, demonstrating that S. aureus overcomes the bacteriostatic nature
of serum through secretion of SA and SB; thus, hts/sfa and sir/sbn could
reasonably be described as virulence loci. In agreement with this statement,
mutations impacting siderophore transport rendered S. aureus attenuated in a
mouse sepsis model of infection.
We have further identified another mechanism by which S. aureus subverts
host molecules for extraction of iron from serum. This mechanism exploits the
propensity of catecholamine neurendocrine stress hormones to interfere with the
iron scavenging capacity of transferrin. In addition to reductively liberating
transferrin iron, these molecules possess 3,4-dihydroxylphenyl groups with
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proposed Fe3+-coordination capacities resembling that of the catecholate family
of bacterial siderophores (15, 35, 45). S. aureus was shown to acquire
transferrin iron via these ligands through the SstABCD transporter, which was
also required for transport of catecholate xenosiderophores. Mutation of sst
enhanced the attenuation phenotype of a staphyloferrin transport mutant.

4.2 Significance of this study
It has long been known that S. aureus is capable of growth in serum and
on transferrin (29, 36, 41), and that catecholamine hormones may enhance this
growth (39). This study is the first to employ a molecular genetics approach
toward describing the genes associated with these processes, and to
comprehensively assess their impact on virulence. Furthermore, this study
complements biochemical characterization of the assembly of staphyloferrin
siderophores using sfa and sbn-encoded NIS synthetases (9, 11), by
establishing these genes encode proteins producing these metabolites in
S. aureus itself.
In combination with the discoveries of other members of our research
group (5, 9, 12, 13, 17, 18, 51), the findings of this study enable the drafting of a
model describing a multifaceted, heme-independent serum iron acquisition
strategy executed by S. aureus, presented in Fig. 4-1. This comprehensiveness
suggests the lowly abundant but highly labile transferrin iron pool to be a vital
reservoir supporting growth of invasive S. aureus. In comparison, published
scientific reports describe only two transport systems involved in acquisition of
heme iron by S. aureus. Furthermore, we have shown that one of these
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transporters, HtsABC, is involved in the transferrin iron strategy, despite its
earlier description as a heme transporter (48). The controversy over its true role
will be addressed in greater detail shortly. The Hts debate notwithstanding,
much has been said about the heme iron preference of S. aureus and its
significance in virulence (30, 42, 48, 55), largely overshadowing contributions
from other potentially significant iron reservoirs.
Despite involving less mechanistic redundancy (based on what is
published to date), heme iron acquisition is certainly crucial for S. aureus
infection. In murine sepsis models of infection, mutants deficient for production
of either staphyloferrin and for acquisition of catecholamine-liberated transferrin
iron were mildly attenuated relative to the wild type, but nevertheless quite
capable of causing severe illness. Conversely, similar observations have been
made for mutants of heme uptake system Isd (31, 55). There is a strong
likelihood that alternate heme transporters are used by S. aureus; beyond
characterizing these, it remains to be seen if combined inactivation of transferrin
and heme iron acquisition mechanisms results in a severely attenuated mutant,
or if alternate mechanisms permit S. aureus to continue to target these host iron
reservoirs and to exploit alternate reservoirs.

4.3 Future investigative foci
4.3.1 What is the intracellular mechanism of Fe3+ liberation from
siderophores?
As implied by the black boxes present in Fig. 4-1, the intracellular fate of
Fe-siderophores in S. aureus is unknown. This information gap is remarkably
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Figure 4-1: Model of transferrin iron acquisition by S. aureus. Secreted
staphyloferrins (SA, left; SB, right) and host-derived catecholamine hormones
(clockwise from top left: norepinephrine, dopamine, L-DOPA, epinephrine)
extract iron from transferrin and are transported through the cell membrane
through transporters HtsABCFhuC (right), SstABCD (centre, shown transporting
Fe-tris-norepinephrine), and SirABCFhuC (left). The intracellular fate of ferrated
ligands is still unknown.
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frequent in the body of literature on microbial siderophores—much is known
about their biosynthesis, target iron reservoirs, and transport, but very few
studies describe their fate once returned, ferrated, to the bacterial cytosol. Is the
mechanism for iron liberation reductive, permitting recycling of the deferrated
siderophore, or destructive, requiring the enzymatic degradation of the molecule
to a catabolite without iron coordination capacity?
It has been suggested that reductive mechanisms likely extract iron from
SA and SB, given that both molecules incorporate amide bonds which are very
resistant to hydrolysis (34). From the limited body of scientific reports, reduction
appears to be the exclusive mechanism for cytosolic extraction of iron from
hydroxamate and α-hydroxycarboxylate siderophores (34). Considering the
range of hydroxamate and α-hydroxycarboxylate siderophores used by
S. aureus, it is likely that multisubstrate reductases are responsible for
siderophore iron extraction. No candidate reductase genes appear to be
encoded on the S. aureus chromosome in the vicinity of any of the siderophore
transport operons (sir, hts, sst, fhu). These might be identified by creating a
transposon mutant library in a Δsfa Δsbn mutant strain and screening for
impaired growth in low iron media supplanted with exogenously derived
staphyloferrins. Impaired siderophore iron extraction might have similar effects
to impaired siderophore transport, i.e. exacerbation of the iron deprivation
response leading to enhanced secretion of unusable siderophore; thus, a
siderophore reductase might make an attractive therapeutic target for small
molecule drugs.
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Destructive mechanisms of iron liberation are typically applied to high
affinity siderophores assembled around bonds that can be efficiently attacked by
water. The catecholate siderophores enterobactin and bacillibactin are
consumed thusly, by iron-regulated esterases that partially or completely
hydrolyze the ester bridges of the trilactone structure scaffolding the catecholate
iron-coordinating groups (27, 33). Destructive liberation also circumvents the
challenge posed to a reductase by the exquisitely high affinity for Fe3+
demonstrated by these siderophores. In this study, clinically relevant S. aureus
strains were characterized growing on ferric bacillibactin and ferric enterobactin
(Fig. 3-9), suggesting they produce the requisite esterase(s) required for
destructive liberation of iron from these siderophores. Bacillus BesA is a broad
specificity esterase capable of cleaving the tri-L-serine trilactone of enterobactin
and the tri-threonine trilactone of bacillibactin; E. coli Fes is a more specific
esterase mediating cleavage of only enterobactin (2). BLAST searches using
these protein sequences failed to uncover any candidate homologues in
S. aureus genomes. Identifying this esterase may provide insight into factors
contributing to intestinal carriage of S. aureus, where iron uptake using coopted
enteric siderophores could contribute to survival. Human intestinal carriage
rates of may be as high as 20% (3), with obvious clinical implications;
surprisingly, this reservoir of S. aureus has received very little scrutiny.
Furthermore, there appeared to be great interstrain variability in responsiveness
to application of these xenosiderophores (Fig. 3-9), which did not correlate to the
amount of SstD expressed by these strains (Fig. 3-5); describing what
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mechanisms dictate activity of this esterase could contribute to our
understanding of niche adaptation by S. aureus strains.

4.3.2 Resolving the hts debate
There is currently an abundance of published evidence unambiguously
describing a role for HtsABC in SA binding and uptake, crowned by the recently
published crystal structure of HtsA liganded to SA (18). Nevertheless, this
transporter is invariably cited as a heme uptake system (16, 30, 49, 50, 54)
based on the findings of Skaar et al. (48), who characterized alterations to the
acquisition profiles of isotopically labelled transferrin and hemin iron resulting
from mutagenesis of putative iron transport systems. Mutating htsB and htsC
biased the iron source preference of S. aureus toward transferrin. Strangely,
this shift was not observed for an isdDEF mutant, despite the characterized
function of IsdE as a heme-binding lipoprotein (37, 43); furthermore, no shifts
toward a heme preference were associated with mutation of sirABC or sstABCD.
Skaar et al. interpreted their findings to signify HtsABC is the primary ABC
transporter of heme in S. aureus, and must work in conjunction with
wall-anchored IsdABC for extraction of heme from host carrier proteins.
While we cannot empirically exclude a role for any Hts protein in heme
transport, we feel it is extremely unlikely to contribute to this process, especially
with regards to HtsA. The three dimensional folding of HtsA places it among the
periplasmic binding protein family alternately referred to as class III (5) or
cluster 8 (24). This family includes siderophore receptors FhuD (10) and SirA
(17), but also heme receptor isdE (19). These demonstrate a conserved
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bi-lobed architecture, the lobes of which are made up of central β-strands
surrounded by several α-helices. The two lobes are bridged by a single long
α-helix, which imparts relative inflexibility ensuring the protein undergoes
minimal conformational change upon ligand binding and release (7, 26, 47).
Beyond an overarching architectural relatedness to IsdE, the HtsA binding
pocket is markedly different from that of its heme-binding counterpart. The
binding groove is shallow and dominated by a large basic patch whose overall
positive charge is the contribution of six arginine residues, conducive to the
binding of an anionic compound such as a staphyloferrin but unlikely to
coordinate a planar, hydrophobic heme molecule (5). The IsdE binding pocket
is hydrophobic, deeper, nearly completely occludes the heme molecule, and is
reliant on heme-iron-coordinating histidine and methionine residues (19).
Importantly, the HtsA protein demonstrates a high affinity for Fe-SA (Kd < 15 nM)
(18); in contrast, multisubstrate binding proteins (e.g. SstD) typically sacrifice
affinity for variety.
With respect to HtsABC, we are at a loss to explain the findings of Skaar
et al. (48). There remains the possibility that HtsBC forms a permease capable
of interacting with multiple receptors, including HtsA for SA and an alternate
lipoprotein. This phenomenon has been characterized in Sinorhizobium meliloti,
whereby operon hmuTUV encodes an ABC transporter comprised of permease
HmuUV which works in conjunction with heme receptor HmuT as well as a
separately transcribed hydroxamate siderophore receptor, FhuP (38). A single
gene ORF encoding a putative class III lipoprotein has been identified as
iron-regulated in vitro (locus tag NWMN_0908) (4), and could be a candidate
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heme receptor. In this case, however, it is unlikely HtsBC is the dominant heme
permease in S. aureus, as we have repeatedly failed to demonstrate a heme
uptake defect associated with the ΔhtsABC mutation in wild type and isdEstrains. The heme transport function of HtsABC is an established paradigm that
merits a courteous but assertive challenge and a more thorough investigation.

4.3.3 Therapeutic strategies targeting siderophore transport
In this study, it was shown that mutagenic inactivation of staphyloferrin
transport did not abrogate staphyloferrin production; on the contrary, SA and SB
secretion was enhanced, and transporter mutants accentuated the iron
withholding capacity of their milieu (Fig. 2-17), presumably further exacerbating
derepression of sfa/sbn and the remainder of the iron starvation regulon from
Fur. In a collaborative study, it was shown that a S. aureus Δfur mutant
constitutively mounts an iron deprivation response regardless of iron availability,
and furthermore demonstrates atypically coordinated expression of virulence
factors despite a lack of direct influence of Fur on the genes involved (54). This
response includes enhanced secretion of leukotoxins and hemolysins, with
decreased expression of surface-associated immunomodulatory proteins. This
disregulated mutant was severely attenuated in a mouse infection model. This
suggests that therapeutics inhibitory to SirA and HtsA functioning might be
especially efficacious in combating S. aureus by essentially coopting bacterial
cells into administering chelation therapy within the infected host, enhancing an
iron starvation response that ultimately compromises virulence.
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In considering exploiting Sir and Hts to combat S. aureus infection,
different strategic approaches can be considered. These include targeting
receptor proteins SirA and HtsA with antibodies to promote bacterial clearance
through opsonization; using said antibodies to block receptor/siderophore
binding; blocking transport using competitive siderophore structural analogs; and
exploiting transporters to deliver toxic siderophore structural analogs into the
cell.
A vaccine-based approach to targeting staphyloferrin receptors intuitively
seems unproductive. Gram-positive lipoproteins are membrane-tethered and
seemingly under the protective canopy of a robust cell wall, which would shield
them from anti-SirA and -HtsA antibodies. Surprisingly, lipoproteins have been
shown to significantly enhance the antigenicity of S. aureus (8). Recently, a
multivalent vaccine against a host of iron-regulated staphylococcal lipoproteins,
including SirA, HtsA, and SstD, has been licensed by pharmaceutical
conglomerate sanofi-aventis Group (1); reports on the vaccine’s efficacy do not
yet exist within the public domain. An independent study has corroborated that
SirA, SstD, and FhuD2 are immunogenic in mammals, and that SstD can be
detected on the surface of S. aureus (52); the protective value of vaccination
with any combination of these components has not been described and merits
further investigation.
With our recently improved understanding of the molecular interactions
between HtsA/SirA and their staphyloferrin ligands (17, 18), and the
biochemistry of staphyloferrin synthesis (9, 11), developing a drug-based
strategy targeting siderophore uptake is also feasible. Siderophore transporters
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could serve as conduits for the delivery of “Trojan horse” molecules to
S. aureus. This principle is at play in the mechanism of albomycin killing of
E. coli. Albomycin is a ferrichrome structural analog with a bound thioribosyl
pyrimidine antibiotic (56). It is recognized by and transported through the E. coli
Fhu transport pathway; in the cytosol, the antibiotic is cleaved off the Fe3+ carrier
by a peptidase and exerts its killing effect (21). Few naturally-occurring
“sideromycins” are known, but our understanding of the structural parameters
defining receptor/staphyloferrin interaction, and our ability to synthesize
staphyloferrins in vitro, could facilitate the design of antibacterial staphyloferrin
analogs permissive to high affinity transport, or alternately, capable of
irreversibly binding to SirA and HtsA.

4.3.4 Characterizing the contributions of staphyloferrins in other host
niches
In this study, two different mouse models were used to characterize the
contributions of siderophore biosynthesis and transport genes toward the ability
of S. aureus to cause acute infection: i) the skin abscess model, and ii) the
sepsis model, which essentially characterizes abscession or colonization of a
limited organ set following bacteremia. Virulence was not detectably influenced
by these genes in the first model, and significantly but modestly influenced in the
second. The ecology and pathology of S. aureus, however, is more expansive
than could be described by these two models, and siderophores may play a
more prominent role in survival in other niches. Beyond colonization of nares,
the rectum, and various regions of the skin, invasive S. aureus can target
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virtually every organ of the body. Siderophores have been shown to contribute
to virulence in other types of infections mediated by other pathogenic organisms,
including pneumonia caused by Klebsiella pneumonia (25), Burkholderia
cenocepacia (57), and Pseudomonas aeruginosa (53), and urinary tract infection
caused by Proteus mirabilis (22). An acute pneumonia model might be
especially pertinent in light of a recent report concluding heme uptake
mechanisms are dispensible to S. aureus in this type of infection (31).
Staphylococcal species, chiefly S. saprophyticus and secondarily
S. aureus, are leading causes of non-E. coli catheter-independent urinary tract
infections (14, 23, 44, 58). Production of multiple siderophores in addition to
enterobactin (notably salmochelin and aerobactin) is an epidemiological marker
strongly associated with uropathogenic strains of E. coli (UPEC) (59).
Additionally, urine is the primary means of catecholamine excretion from the
body, and may contain micromolar concentrations of these molecules.
Siderophore iron uptake thus might play a noteworthy role in staphylococcal
urinary tract infections, yet nothing is currently known about the contributions of
staphyloferrins, UPEC siderophores, and catecholamines.
Siderophores may also be important for asymptomatic colonization of the
host. Siderophores are invariably overlooked in reviews on S. aureus factors
enabling carriage among humans. Iron availability at colonized sites is low,
however, in part due to lactoferrin, a normal component of mucous.
Furthermore, S. aureus may have to compete for iron with other commensalist
bacteria producing their own siderophores. In addition to expressing
transporters for coopting siderophores produced by other species (Fhu and Sst),
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it is tempting to speculate that production of a second staphyloferrin, SB, may
offer a selective advantage to S. aureus over CNS species that are otherwise
genetically homologous in terms of siderophore transport (Fhu, Sst, Hts) and
biosynthesis (SA). It would be interesting to evaluate the fitness of S. aureus
siderophore mutants in murine models for colonization (46),
colonization/transmission (6), and colonization/competition (40).
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Appendix 1
Systemic infection trials with Jackson Laboratories mice
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Figure A1. S. aureus Newman strains mutated in sfa and sbn loci are not
attenuated in a mouse sepsis model of infection. Approximately 8 x 106
CFU (A) or 2 x 106 CFU (B) S. aureus Newman and an isogenic staphyloferrin
biosynthetic mutant derivative were injected intravenously to Jackson
Laboratories BALB/c immunocompetent mice. Percentage of mouse body mass
lost over four days and CFU recovered from target organs are plotted.
Statistical analysis was performed using the Student’s unpaired t-test. No
signficant treatment differences were noted. Calculated infective doses, in
millions of CFU injected, were as follows: wild type (WT), 7.775 (A) and 2.100
(B); Δsfa Δsbn, 10.050 (A) and 2.300 (B).
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Figure A2. Mutation of S. aureus Newman at sst enhances attenuation in
a mouse sepsis model of infection. Approximately 1 x 107 CFU S. aureus
Newman and isogenic iron transport mutant derivatives were injected
intravenously to Jackson Laboratories BALB/c immunocompetent mice.
Percentage of mouse body mass lost over four days and CFU recovered from
target organs are plotted. Statistical analysis was performed using the Student’s
unpaired t-test. Asterisks denote significant differences (P < 0.05) from wild
type (WT) (*) or from an isogenic sst+ parent (**). Infective doses were as
follows (in millions of CFU/dose): 7.75 (WT), 10.50 (Δsbn Δsfa), 8.50 (sirA::Km
Δhts), 13.25 (Δsst), 11.00 (Δsbn Δsfa Δsst), 9.25 (sirA::Km Δhts Δsst).
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Summary of this work:
Infection trials were performed as described in Chapters 2 and 3.
Virulence data presented in those chapters were generated using mice
purchased from Charles River. In those trials, siderophore biosynthesis mutants
of S. aureus did not demonstrate robust attenuation phenotypes, conflicting with
an earlier report describing a strong attenuation phenotype resulting from
insertional inactivation of sbnF (1).
Animal vendors post online reports of infectious agent outbreaks in their
breeding colonies. Upon examination of the Charles River reports, it was
determined that the mice used for the experiments described in Chapters 2
and 3 may have had prior exposure to S. aureus, which could have altered their
immunity to the pathogen for subsequent infection studies. It was therefore of
interest to repeat the experiments using mice from breeding colonies with
immaculate surveillance histories, as were available for purchase from Jackson
Laboratories.
Data generated using Jackson Laboratories mice were in good agreement
with those generated using Charles River mice. In summary, inactivation of
siderophore biosynthesis (Δsfa Δsbn) did not reduce the virulence of S. aureus;
inactivation of siderophore transport (Δhts sirA::Km) reduced virulence in livers
and hearts; and inactivation of catechol transport (Δsst) in combination with
inactivated siderophore transport or biosynthesis reduced virulence in kidneys,
livers, and hearts.
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Appendix 2
sbnA and sbnB are required in generating L-2,3-diaminopropionic acid for
staphyloferrin B biosynthesis
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Summary of this work:
In addition to encoding synthetases SbnC, SbnE, and SbnF (1), the sbn
operon includes genes for putative accessory enzymes that might play a role in
substrate generation. The assembly of SB requires the input of two molecules
of the rare, nonproteinogenic amino acid L-2,3-diaminopropionic acid (L-DAPA)
(Figure 1-5B).
BLAST analyses revealed SbnA shares identity with an amidotransferase
(VioB) and SbnB shares identity with an ornithine cyclodeaminase (VioK)
encoded by the viomycin biosynthetic cluster of Streptomyces vinaceus
(E values of 2e-45 and 5e-37, respectively). S. vinaceus produces viomycin from
precursors including L-DAPA (3). It was hypothesized that the concerted roles
of SbnA and SbnB might be to generate L-DAPA from L-ornithine and L-serine,
whereby ammonia released from the cyclization of L-ornithine to L-proline by
SbnB would be used as a nucleophile by amidotransferase SbnAB to aminate
L-serine

to L-DAPA (Figure A3).

To test the hypothesis that SbnA and SbnB are required to produce
L-DAPA

for siderophore biosynthesis, attempts were made to rescue low-iron

growth defects of S. aureus Newman sbnA and sbnB insertional inactivation
mutants (Table A1) using L-DAPA. Mutations were transduced into the Δsfa
background (Table 2-1) to eliminate the compensatory function of SA. On
10 µM human holotransferrin as a sole iron source, the growth defects of
sbnA::Km and sbnB::Km mutants but not that of the ΔsbnABCDEFGHI (Δsbn)
mutant were rescued by application of 5 mM L-DAPA (Figure A3, A and B), but
not its isomer D-DAPA (Figure A3, B) or the other predicted product of the
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SbnA/SbnB reation, L-proline (Figure A3, C). Furthermore, L-DAPA restored the
siderophore output of the sbnA/sbnB mutants, as measured using the CAS
assay (Figure A3, E and F). The sbnA/B mutant phenotypes were also
complementable in trans by expressing wild type copies of the genes from
vector pALC2073 (Figure A3, D). A final noteworthy observation was that
exogenous application of L-DAPA massively increased the siderophore output of
a sbn wild type strain (Figure A3, F), suggesting that procurement of this
molecule may be a limiting factor in SB production.

Materials and methods
The sbnA::Tc and sbnB::Tc mutant alleles and vectors for complementing
these mutations in trans were generated using methodologies described in
Chapters 2 and 3. Additional details are summarized briefly below:
To create an inactivation allele, sbnA was PCR amplified using primers
with engineered SacI and KpnI restriction sites and cloned into vector pBC SK+
between those sites. A tetracycline resistance cassette was PCR amplified from
vector pDG1513, digested with restriction enzymes NsiI and PstI, and ligated
into a unique NsiI restriction site in sbnA within pBC SK+; this allele was excised
and ligated into temperature-sensitive suicide shuttle vector pAUL-A using
restriction enzymes KpnI and SacI, then integrated via double homologous
recombination into the S. aureus RN6390 chromosome, and transduced to other
strains essentially as described in Chapters 2 and 3. To generate a
complementation vector, sbnA was PCR amplified using primers with
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engineered XhoI and EcoRI restriction sites and cloned directly to pALC2073,
creating plasmid pFB5.
To create an inactivation allele, sbnB was amplified using primers with
engineered BamHI sites but cloned as a blunt-ended PCR product to vector
pACYC184 digested with EcoRV. A tetracycline resistance cassette was
excised from vector pDG1514 with restriction enzymes NsiI and PstI and ligated
into a unique PstI restriction site in sbnB within pACYC184; this allele was
excised and ligated into temperature-sensitive suicide shuttle vector pAUL-A
using restriction enzyme BamHI, then integrated via double homologous
recombination into the S. aureus RN6390 chromosome prior to transduction. To
generate a complementation vector, sbnB was PCR amplified using primers with
engineered EcoRI restriction sites and cloned directly to pALC2073, creating
plasmid pSED52.
For growth assays, bacteria were cultured in C-TMS with human
holotransferrin as described in Chapter 2. Amendments to the medium included
5 µg/mL chloramphenicol (Bioshop) (complementation assay only), 5 mM L- or
D-2,3-diaminopropionic

(Sigma-Aldrich).

acid (Iris Biotech GmbH), or 5 mM L-proline
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Figure A3. Proposed reactions for SbnA/SbnB-mediated generation of
L-diaminopropionic

acid from ornithine and serine.
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Table A3: Bacterial strains, plasmids, and oligonucleotides used in this
study (see also Tables 2-1 and 3-1)
Description

Ref.

H2131

Newman sbnA::Tc ΔsfaABCsfaD::Km

This study

H1718

Newman sbnB::Tc ΔsfaABCsfaD::Km

This study

pACYC184

E. coli cloning vector; CmR

ATCC

pDG1514

pMTL23 derivative carrying tetracycline
resistance cassette; ApR

(2)

pFB5

pALC2037 derivative carrying sbnA; CmR

This study

pSED52

pALC2037 derivative carrying sbnB; CmR

This study

S. aureus strains

Plasmids

Oligonucleotides*
sbnA5’-SacI
sbnA3’-KpnI
Tet5’-NsiI
Tet3’

sbnA5’-XhoI
sbnA3’-EcoRI
sbnB5’-BamHI
sbnB3’-BamHI
sbnB5’-EcoRI
sbnB3’-EcoRI

5’ TGAGCTCGATTCTGTAGGGCAAACACC 3’
5’ TTGGTACCTCTAAGTAACGATCGCCTCG 3’
Cloning of sbnA into pBC SK+
5’ TTGTATATGCATACGGATTTTATGACCGATGA 3’
5’ TGTGTGGAATTGTGAGCGGATAAC 3’
Amplification/cloning of a tetracycline resistance cassette
from pDG1513
5’ TTTCTCGAGATTTTAAATTTGAGGAGGAA 3’
5’ TTTGAATTCCCACATAAACTTGTGAATGATT 3’
Cloning of sbnA into pALC2073
5’ TTGGATCCTAGTTTATTCAGATACATGG 3’
5’ TTGGATCCTGTCCCAATATTTTGTTGTT 3’
Cloning of sbnB into pACYC184
5’ TTGAATTCTCAAGTGATCCATGTAGATG 3’
5’ TTGAATTCCAATTCCGGCTATATCTTCA 3’
Cloning of sbnB into pALC2073

* underlined sequences in oligonucleotides denote restriction sites
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Figure A4. Low iron growth defects resulting from inactivation of sbnA
and sbnB can be rescued with L-DAPA. S. aureus Newman mutants (all
Δsfa) were grown in C-TMS containing 10 µM human holotransferrin
(approximately 60% saturated). (A; E) Inactivation of sbnA or sbnB, or deletion
of the entire sbn operon, resulted in a growth defect, which could be rescued by
addition of 50 µM FeCl3 (inset); this was due to loss of siderophore output, which
could be repressed in the wild type by addition of FeCl3 (inset). (B; F) For the
sbnA/B mutants this defect could be rescued by application of L-DAPA (L) but
not D-DAPA (D); L-DAPA restored siderophore production. (C) L-proline could
not rescue growth defects. (D) sbnA/B mutant growth defects could be rescued
by expression of wild type copies of those genes from a plasmid.
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